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Abstract
Document recommendation systems for locating relevant literature have mostly relied
on methods developed a decade ago. This is largely due to the lack of a large ofﬂine
gold-standard benchmark of relevant documents that cover a variety of research ﬁelds
such that newly developed literature search techniques can be compared, improved
and translated into practice. To overcome this bottleneck, we have established the
RElevant LIterature SearcH consortium consisting of more than 1500 scientists from 84
countries, who have collectively annotated the relevance of over 180 000 PubMed-listed
articles with regard to their respective seed (input) article/s. The majority of annotations
were contributed by highly experienced, original authors of the seed articles. The
collected data cover 76% of all unique PubMed Medical Subject Headings descriptors.
No systematic biases were observed across different experience levels, research ﬁelds
or time spent on annotations. More importantly, annotations of the same document
pairs contributed by different scientists were highly concordant. We further show that
the three representative baseline methods used to generate recommended articles
for evaluation (Okapi Best Matching 25, Term Frequency–Inverse Document Frequency
and PubMed Related Articles) had similar overall performances. Additionally, we found
that these methods each tend to produce distinct collections of recommended articles,
suggesting that a hybrid method may be required to completely capture all relevant
articles. The established database server located at https://relishdb.ict.grifﬁth.edu.au is
freely available for the downloading of annotation data and the blind testing of new
methods. We expect that this benchmark will be useful for stimulating the development
of new powerful techniques for title and title/abstract-based search engines for relevant
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When drafting a manuscript such as this article, a survey of
relevant literature and related articles from the same sub-
field is required. Traditionally, such a survey is conducted
by combining searches based on specific keywords and
references found in bibliographies (i.e. references citing,
or cited in, the selected articles). This process requires
multiple attempts of different keyword combinations and
manual examination of numerous citations. A long list
of both relevant and irrelevant articles is often encoun-
tered requiring manual curation after further reading, yet
not all of the important relevant articles are necessarily
included after this long and tedious process. The task of
finding truly relevant articles becomes increasingly time-
consuming and challenging as the number of scientific
articles published every year expands at a rapid pace.
For example, the PubMed (http://www.ncbi.nlm.nih.gov/
pubmed) database operated by the US National Center
for Biotechnology Information at the US National Library
of Medicine (NLM), has seen a sustained annual growth
rate of nearly 5% for the past 4 years; from 25.2 million
records in 2015 (57), 26.4 million records in 2016 (58),
27.5 million records in 2017 (59) and is now approaching
29 million records in 2018 as of the latest report (66).
The overall success of this classic approach depends on
finding optimal keyword combinations as it is key for
ensuring the precision and completeness (i.e. sensitivity)
of the search results.
The aforementioned scenario is an illustration of
an ‘informational’ search goal (8, 64), essentially an
exploratory request for discovering the most relevant
resources to ‘find out’ about a particular topic. For purely
‘navigational’ queries that seek out a single ‘correct’ result
(8, 64), the classical keyword based approach is generally
sufficient. However, for a more complete survey, the
keyword input given by the user is susceptible to a number
of rigidities including misspellings, ambiguity and desired
scope. To address these challenges, traditional search engine
operators implement various workarounds including query
spelling correction, query suggestions, query reformulation
and query expansion. A recent NLM study describing
‘under-the-hood’ improvements to PubMed demonstrate
the integration of such mitigation techniques (25). As this
problem remains unsolved, alternative approaches may be
employed.
One way to avoid keywords in searches is to use a seed
article. A seed article can provide the title, the abstract and
even its full text, containing significantly more information
than a combination of a few pre-selected keywords. Aside
from these content-based features, seed articles may also
provide additional metadata including the list of authors,
publication venue and date, citation information and poten-
tially manually curated categorical information such as
assigned Medical Subject Headings (MeSH) descriptors
(52). Most importantly, all of these features are extracted
and processed automatically without requiring any user
input or intervention. Thus, for an article-based search, the
search engine will accept as input either the selection of an
existing document from its database or a user uploaded doc-
ument in its entirety, in order to generate the list of results.
Article-based relevance searches, often referred to as
research paper recommender systems, is an active area
of research with more than 100 different approaches
published since 1998 (7). Representative examples of
commonly used methods used for calculating the similarity
between text documents are Okapi Best Matching 25
(BM25) (39, 40), Term Frequency–Inverse Document
Frequency (TF-IDF) (65) and PubMed-Related Articles
(PMRA) (49). These and other decade-old methods remain
the backbone behind real-world recommender systems
such as PubMed (http://www.ncbi.nlm.nih.gov/pubmed),
ResearchGate (http://www.researchgate.net) and CiteULike
(http://www.citeulike.org). Numerous newly developed
methods are not yet translated into practice because it
is unclear whether they have improved over existing
methods (7).
Improvements in paper recommender systems can be
measured by ‘user studies’, ‘online evaluations’ or ‘offline
evaluations’.User studies aim to quantify user experience by
interacting directly with explicit testers of the system; online
evaluations are a more passive approach wherein user
activity is silently monitored and recorded for assessment,
and offline evaluations are akin to traditional benchmark-
ing processes where algorithmic performance measures
are evaluated on appropriate datasets. The problem with
user studies and online evaluations is that considerable
active participation is required to infer any meaningful
conclusions (7). Accordingly, a large-scale user study would
require costly recruitment and management of a large
number of participants, whereas for online evaluations
it is challenging to attract large numbers of active users
to a deployed system except for a few systems with
large established user bases. Moreover, the data used
for evaluating such systems are often not made publicly
available. In addition, online evaluations collect implicit
measures of satisfaction such as click-through rates;
however, non-clicked items are not necessarily an indicator
of negative samples.
Offline evaluations, on the other hand, require a gold-
standard benchmark for comparing and contrasting the per-
formances of different systems. Previous work has focused
on building gold standards of query-to-document relevance
in biomedical literature. Queries are generally defined as
some topic comprised as a natural language statement,
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information need. Representative examples of existing
gold-standard query-to-document resources include the
OSHUMED (32) collection, the first TREC Genomics
track (33, 73) (the only applicible biomedical-focused
track within TREC), the BioASQ (72) competition and
the bioCADDIE (13) dataset. Although these datasets are
suitable for benchmarking traditional information retrieval,
they do not consider the similarity between document pairs
as a whole. Re-purposing query-to-document datasets to
the document-to-document similarity problem has been
attempted; for example, adaptation of the 2004/2005
TREC Genomics data (34, 35) has been evaluated by
previous studies (11, 49, 74). However, a pair of documents
may both be related to a certain topic but only loosely
related to each other as complete units.
Constructing a gold standard dataset of sufficient size
for offline evaluations is not a trivial endeavor. In the
context of query-to-document relevance, a recent study
concluded that ‘there is unfortunately no existing dataset
that meets the need for a machine-learning-based retrieval
system for PubMed, and it is not possible tomanually curate
a large-scale relevance dataset’ (24). We propose here that
relevance labels between document pairs in the document-
to-document context can be ‘crowd-sourced’. This ideol-
ogy has a number of successful applications; for example,
computational resources are crowd-sourced by the BIOINC
(1) distributed computing system for the Folding@Home
(47) and Rosetta@Home (28) projects, and human problem
solving resources are crowd-sourced for ‘distributed think-
ing systems’ as in the Foldit (14, 28) project.
Here, we have established the RElevant LIterature
SearcH (RELISH) consortium of 1500+ scientists from 84
countries around the world.The consortium annotated over
180,000 document–document pairs indexed by PubMed,
nearly 400 times larger than the single other human
annotated data collection we could find with just 460
annotations by 90 authors (50). Analysis of the collected
data indicates diversity and consistency of annotations
across different levels of research experience as well
as its usefulness in benchmarking different document–
document comparison methods. Futhermore, these data
could be utilized in future work to train deep machine
learning models that may substantially increase relevancy
of recommendations compared to existing methods.
Methods
The overall procedure for establishing the RELISH
database was as follows. First, we established the article-
based PubMed search engine (APSE; https://pubmed.ict.
griffith.edu.au) for recommending articles (‘candidate-
articles’) potentially relevant to an input article (‘seed-
article’) given by, or assigned to, a user. The APSE allowed
users to assess and annotate recommended candidate
articles regarding their degree of relevance to a respective
seed article and facilitated submission of these annotations.
Then, we established the RELISH consortium of scientific
authors (‘participants’) and invited them to the APSE
to evaluate 60 candidate articles for one or more seed
articles that they are interested in or, preferably, they have
authored. Finally, annotations submitted by participants
were compiled and organized into the RELISH database. A
participant’s ‘contribution’ was defined as the submission
of annotations for all 60 candidate articles with respect to
a seed article.
The remainder of this section explains database con-
struction, including the APSE’s corpus data and candidate
article recommendation methods, participant recruitment
and annotation procedures and performance evaluation
metrics.
APSE: document corpus
The seed article corpus used by the APSE server was
extracted from the biomedical literature database hosted
by PubMed. The corpus database was constructed using
the 2017 baseline downloaded from PubMed’s public FTP
server (ftp://ftp.ncbi.nlm.nih.gov/pubmed), followed by
incremental synchronization with daily update releases.
Only articles with available title and abstract metadata
were included in the corpus, no other selection criteria
were imposed. As of 3 July 2018, this collection contained
18,345,070 articles, from which participants selected seed
articles.
The candidate article corpus, from which the APSE
server generated recommendations that were presented to
participants, was a subset of the seed article corpus. This
subset included only recent articles that were published
within the past decade. The primary justification for this
was to increase participant motivation with potential dis-
covery of recent work within their field, considering the
decline of participation willingness with increasing publi-
cation age as speculated previously (77). As of 3 July 2018,
this candidate article subset contained 8,730,584 articles.
All raw article texts were pre-processed into usable
indexing elements (tokens) by the following pipeline. We
first applied Lucene’s ‘UAX29URLEmailTokenizer’, which
follows Unicode Text Segmentation rules (16) to divide the
text (while also tagging detected URLs or email addresses).
Next, possessives (trailing apostrophe + s) were removed
from each token, and any single character, numeric, URL
or email tokens were removed. Stop-word tokens were
filtered according to a list of 132 official MEDLINE
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tokens were stemmed to their root form using Lucene’s
‘PorterStemFilter’.
APSE: recommendation system
The APSE recommendation system is built on three baseline
methods: PMRA (49), BM25 (39, 40) and TF-IDF (65).
PMRA is the technique used by the ‘Similar Articles’ func-
tion on the official PubMed site. Here we used the Entrez E-
utilities (43) ELink to retrieve related articles for given seed
articles. BM25 is a representative probabilistic relevance
technique, implemented here by Lucene’s ‘BM25Similarity’
class using default parameters of k1 = 1.2 and b = 0.75.
TF-IDF is a representative vector space model technique,
implemented here by Lucene’s ‘ClassicSimilarity’ class.
For the individual method evaluations presented in this
study, the original method-specific list of results were used
(in this case the same candidate article may be shared by
multiple methods). Each method’s list of candidate articles
was sorted by descending score. To generate the list of
recommendations presented to the user for annotation,
we took the individual method-specific result lists and
combined them into a unified list. We set a maximum of
60 articles per seed article so as to include at least the
top 20 highest-scoring non-redundant candidate articles per
method.
The unified list assembly procedure is as follows: in
a round-robin fashion between all methods, consider the
current top-scoring article from a method. If the article
is not already in the unified list, add it. Otherwise, disre-
gard this article and continue with the next best-scoring
article until an addition to the unified list has been made.
Essentially, this procedure is performing a three-way merge
while ensuring an equal selection of non-redundant rec-
ommended articles from each method. This unified list
of recommendations was not presented in the order of
predicted similarity. Instead, before presentation to users,
it was shuffled randomly to reduce the possibility of a
systematic bias in annotation.
RELISH: participant recruitment
To achieve the goal of a large dataset facilitating future deep
machine learning-based method development, we estab-
lished the RELISH consortium of biomedical researchers
who have annotated studies potentially related to one or
more seed articles that they had authored or were interested
in. To maximize the quality and efficiency of annotation,
we encouraged participants to use articles that they had
authored as the seed articles. All participants contributed
voluntarily. Only submissions with annotations completed
for all 60 recommended candidate articles per seed article
were accepted.
Our recruitment strategy involved two major phases:
the first was internal referrals, personal invitations, social
media posts and a correspondence letter (9); the second was
directly contacting authors of papers published in 2018. For
this secondary phase, we built a contact list of the corre-
sponding authors with 2018 papers indexed in PubMed
Central (63) and created a personalized email including
the top three candidate articles (the highest-scoring non-
redundant document from each method) relating to their
article along with an invitation to join our consortium.
A total of 129,190 unique authors were contacted
regarding 72,764 unique PubMed articles. Of these articles,
54,071 (74.3%) had contact information for a single author
only (assumed to be the corresponding author), 7452
(10.2%) had contact information for two authors (assumed
to be first and corresponding authors), while the remainder
had contact information for more than two authors. In
any case, all available contacts per article were invited, as
to encourage multiple annotators of the same article for
consistency analysis.
Finally, of the 1570 total unique participants, we had
342 (21.8%) participants join by the initial recruitment
phase. During the secondary recruitment stage, 1228
(78.2%) authors accepted our invitation yielding an overall
response rate of 0.95%, thus the majority of contributions
resulted from this phase.
RELISH: annotation procedure
An overview of the annotation procedure is shown in
Figure 1. Each participant was asked to annotate the degree
of relevance (‘relevant’, ‘somewhat-relevant’ or ‘irrelevant’)
between a seed article and recommended candidate articles.
We gave the following definitions for the degrees of rele-
vance as a guide for label assignment:
1. Relevant: an article topically relevant to the seed
article; within the same specific sub-field of research,
i.e. an article that would be interesting to read further
or could have been cited within the original work.
2. Somewhat-relevant: an article missing some key top-
ical details of the seed article; within the broader
area of research but does not specifically fit into the
sub-field, i.e. unlikely to be considered for a citation
within the original work.
3. Irrelevant: an article unrelated to the seed article and
obviously does not fit inside the specific sub-field of
research.
Although definitions of ‘relevance’ are subjective, we aimed
to make the choice as simple as possible by using this three-
point system of document pair ‘closeness’, as opposed to a
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Figure 1. An overview of the four stages comprising the annotation procedure. In step 1, the title or PubMedID of a desired seed article is searched;
in step 2, a seed article is selected; in step 3, the result list is presented to the participant for annotation; and in step 4, all annotations are reviewed
before being submitted to the database.
point scales (44). Additionally, this three-point scale befits
collapse to binary classification (a two-point ‘positive’
or ‘negative’ scale); the ‘relevant’ and ‘irrelevant’ classes
intuitively map to the ‘positive’ and ‘negative’ classes,
respectively, leaving only the ‘somewhat-relevant’ class
to be mapped to either the ‘positive’ or ‘negative’ class
depending on required evaluation strictness.
Before submitting annotations, contributors were asked
to provide their level of experience from the following
options: PhD student, years of experience after PhD studies
(less than 5, between 5 to 10 or more than 10) and other
(unspecified, potentially comparable to PhD experience
with degrees like MD or PharmD).
Evaluation metrics
The expert-annotated document pairs provided the oppor-
tunity to evaluate the performance of the three baseline
methods for the first time. To simplify the evaluation, we
collapsed our three-state label classes to fit a two-state
classification in which, unless stated otherwise, ‘relevant’
seed candidate article pairs were assigned to the ‘positive’
class, while ‘somewhat-relevant’ or ‘irrelevant’ article pairs
were assigned to the ‘negative’ class. Using this stratifica-
tion, we assessed method’s performances using both binary
classification and information-retrieval metrics.
For binary classification metrics, we used Matthews
correlation coefficient (MCC) and area under the [receiver
operating characteristic (ROC)] curve (AUC). Metrics used
for information-retrieval are precision of top-N ranked
results (P@N) and mean reciprocal rank (MRR). MCC
and AUC emphasize good discrimination between ‘positive’
and ‘negative’ classes, whereas P@N and MRR metrics
emphasize highly ranked ‘positive’ class results.
MCC (54) is the elective metric of the machine learning
community for summarizing classification performance;
although it is not restricted to binary classification in par-
ticular, for the binary case, it coincides with the square root
of the chi-squared statistics (42). Using a variable similarity
score threshold parameter, contingency tables measuring
separation between positive and negative classes are gen-
erated, from which the MCC is determined. Here, we have
reported the maximum value. A balanced measure is given
even when the distribution of ‘positive’ and ‘negative’ class
instances are unbalanced (5), where perfect classifications
are given a MCC value of 1 and random classifications are
given a MCC value of 0.
AUC (29) is determined by a ROC, a plot of sensitivity
as a function of specificity at varying threshold parame-
ter values. The area under this ROC curve estimates the
probability that a classifier would rank a randomly chosen
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instance (23), where perfect classifications are given an
AUC value of 1 and random classifications are given an
AUC value of 0.5.
P@N (15) is the proportion of results assigned to the
‘positive’ class within a fixed N of top ranked results. Here,
we have reported N values of 5, 10 and 20; 5 and 10
were chosen as a measure of ‘first-page’ results initially seen
by users, and 20 was used as an indication of the total
‘positive’ class proportion per method (as there only 20
results considered per seed article for individual method
evaluation). However, P@N is limited by weighting equally
each result within the top-N.
MRR (62) measures average closeness of the first ‘pos-
itive’ class result to the top of its result list over a sample
of queries Q. Here, not all positions are weighted equally,
highly ranked ‘positive’ class results are rewarded more
than lower-ranked ones. It is determined by averaging the
reciprocal rank (RR), i.e. 1/ranki, where ranki is the posi-
tion of the first encountered ‘positive’ class result in a list
of putative matches, for each query in Q. An MRR value
of 1 indicates that for each query, the highest ranked result
belonged to the ‘positive’ class.
Infrastructure
The database search infrastructure was powered by Elas-
ticsearch [https://github.com/elastic/elasticsearch; using
Apache Lucene (https://github.com/apache/lucene-solr)].
The web interface was designed using React (https://github.
com/facebook/react), web services were built using Apache
(https://github.com/apache/httpd) and Python (https://
github.com/channelcat/sanic) and data were organized
using MongoDB (https://github.com/mongodb/mongo).
Results
Here we introduce RELISH-DB, the database that resulted
from the annotation work of the RELISH consortium. All
annotations submitted by participants before 27 July 2018
were consolidated into the initial revision of RELISH-DB.
The remainder of this section presents statistics of
database content and consortium participation, and the
results for annotation consistency analyses and method
performance evaluations.
Annotations were contributed by a diverse group
of highly experienced original authors
Table 1 shows simple statistics of RELISH-DB content
according to participants’ research experience. Annotations
were received from a total of 1643 unique scientists around
the world, of whom 1570 are registered participants
(affiliated consortiummembers) and 73 contributed anony-
mously. Figure 2 shows that the contributors to this project
originated from diverse geographic locations, including
84 unique countries with the largest clusters located in
Europe (586), North America (356), China (265) and
Oceania (161). Altogether, the participants annotated 3017
seed articles or 181,020 (3017×60) labelled document
pairs. The average number of submissions per participant
was 1.9 (all anonymous submissions were considered as
individuals). The majority of participants (77%) submitted
annotations for just one seed article, 11% for two, 3% for
three and 9% for four ormore, respectively.A few dedicated
participants annotated more than 50 seed articles. The
majority of contributions (63%) were made by experienced
researchers with 5 or more years’ experience post-PhD.
More significantly, the majority of seed articles (91%) were
evaluated by one of the original authors according to name
matches. These statistics suggest high-quality annotations
within RELISH-DB.
Annotations covered diverse research areas
Figure 3 shows a word-cloud distribution ofMeSH descrip-
tor frequencies for all annotated documents, normalized by
baseline frequencies in all PubMed documents. There seems
to be a slight over-representation of publications on high-
throughput ‘Omics’ technologies (e.g. genomics, genome-
wide association study, nucleotide sequencing, proteomics).
It is possible that researchers in the field of bioinformatics/
computational biology were particularly eager to partic-
ipate in the study of annotating documents as they are
probably the ones seeing the most benefit in having a large
annotated dataset of high quality. It may also be due to the
first participant recruitment phase via internal referrals and
personal invitations were somewhat enriched with scientists
working in the bioinformatics/computational biology areas.
On the other hand, it could simply reflect the general trend
in biomedical research of using more and more ‘Omics’
technologies. Nevertheless, the diversity of annotated con-
tent was illustrated by a 76% coverage of all unique MeSH
descriptors in the official PubMed library collection by
all documents within RELISH-DB (every seed article plus
every candidate article per seed article). Such a diversity
in research fields is important for benchmarking literature-
searching tools applicable to all biomedical research fields.
Partial relevance was the most popular
annotation
The distribution of the three possible relevance labels (rele-
vant, somewhat-relevant and irrelevant) across all contri-
butions per seed article is shown in Figure 4. The chart
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Table 1. Distribution of database content by participant experience level. Registered and anonymous
columns show the number of participants at respective experience levels. Contributions is the total number
of seed articles evaluated by participants at respective experience levels.
Registered Anonymous Contributions
PhD (>10 years) 652 (41.5%) 34 (46.6%) 1391 (46.1%)
PhD (5–10 years) 249 (15.9%) 7 (9.6%) 512 (17.0%)
PhD (<5 years) 283 (18.0%) 14 (19.2%) 538 (17.8%)
PhD (student) 191 (12.2%) 11 (15.1%) 282 (9.3%)
Other 195 (12.4%) 7 (9.6%) 294 (9.7%)
Total 1570 73 3017
Note: contribution total includes both registered and anonymous submissions.
Figure 2. Distribution of participant geolocation. There are 1570 registered participants from 84 unique countries. The majority of contributors are
from Europe, North America, China and Australia.
candidate articles in respective relevance labels. It should
be noted here that the frequency refers to the proportion of
all 3017 seed articles, and the sum of frequencies in each
column is not 1. For example, considering the column at
zero number of articles, it should be interpreted that for
relevant, 2.7% or 84 seed articles have no candidate articles
marked as relevant. Summing 2.7%, 0.5% and 9.7% for
respective relevance labels means that 12.9% or 392 seed
articles in total have no candidate articles in one of the
relevance labels. The peaks for relevant, somewhat-relevant
and irrelevant annotations was at 8 (106 articles, 3.5%), 17
(113 articles, 3.7%) and 0 (291 articles, 9.7%), respectively.
These distribution peaks suggest that many articles fell
into the grey area of partial relevance. Additionally, the
preference for partial relevance can be observed from the
box plot on the right side of Figure 4 where the median
number of somewhat-relevant candidate articles per seed
article is 20, compared to 17 for relevant and 16 for
irrelevant. Furthermore, when considering the average and
standard deviation of candidate articles per seed article
in each relevance label, somewhat-relevant had the high-
est average and the lowest deviation of 21 ± 11, com-
pared to 19 ± 14 for relevant and 19 ± 15 for irrelevant.
The overall dominance of relevant and somewhat-relevant
annotations suggests the reasonable performance of the
three baseline methods in filtering out obviously irrelevant
articles.
Consistency according to method performance
Our definition of relevance, partial relevance and irrele-
vance is subject to different interpretations by different
individuals. The perceived efficacy of document recommen-
dation systems depends on the expected agreement between
the subjective opinions of different individuals. To examine
if such agreement exists, we compared the performance of
the three baseline methods on annotations made by scien-
tists of different experience levels, annotations of the same
articles by different individuals, annotations across differ-
ent research fields and durations of time spent annotating.
To carry out these comparisons, seed articles for
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Figure 3. Word cloud of the 250 most frequent MeSH qualiﬁers from all seed articles normalized by frequencies in the whole PubMed library. In
total, unique qualiﬁers present in the seed article collection (i.e. each seed article with its recommended candidate articles) cover 76% of all unique
MeSH qualiﬁers.
Figure 4. Left: frequency of seed articles (y-axis) containing n annotated candidate articles of respective labels (x-axis). Right: distribution of annotated
candidate articles across all seed articles. Boxes represent the quartiles; middle lines are the median values.
according to the following conditions. First, we removed
44 seed articles that PMRA provided fewer than 20 article
recommendations for; this was to ensure a fair comparison
with the other baseline methods that will always have 20
recommendations per seed article. Next, 186 seed articles
without any positive or negative samples were removed
as assessment of discrimination is impossible when all
candidate articles belong to either the positive or negative
class. Finally, we set aside 154 duplicate annotations of the
same seed article by different participants (‘D154’), and
400 randomly selected seed articles as an independent test
set (‘T400’), to be analyzed separately.
This led to a total of 2233 seed articles (‘ALL2233’)
available for evaluation. From this set we derived an ‘NR’
(non-redundant) set, comprised of a single seed article from
each unique participant to avoid potential bias against spe-
cific annotators. In this dataset, for participants with multi-
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Table 2. Overall evaluation set performance results for the PMRA, BM25 and TF-IDF methods. ‘ALL’ includes all seed
articles from all participants, and ‘NR’ includes only one seed article from each participant, corresponding to the
‘ALL2233’ and ‘NR1220’ sets, respectively. Performance was measured using MCC, AUC (ROC), MRR and P@N, given as
(mean ± stdev).
# MCC AUC MRR P@5 P@10 P@20
ALL PMRA 2233 0.494 ± 0.23 0.675 ± 0.19 0.850 ± 0.28 0.614 ± 0.31 0.538 ± 0.29 0.464 ± 0.27
BM25 0.509 ± 0.22 0.687 ± 0.18 0.859 ± 0.28 0.622 ± 0.30 0.536 ± 0.28 0.457 ± 0.27
TFIDF 0.510 ± 0.22 0.688 ± 0.18 0.873 ± 0.27 0.634 ± 0.30 0.541 ± 0.28 0.463 ± 0.27
NR PMRA 1220 0.479 ± 0.22 0.664 ± 0.19 0.868 ± 0.27 0.639 ± 0.29 0.565 ± 0.28 0.492 ± 0.27
BM25 0.498 ± 0.22 0.675 ± 0.18 0.878 ± 0.26 0.642 ± 0.29 0.559 ± 0.27 0.481 ± 0.26
TFIDF 0.511 ± 0.22 0.685 ± 0.18 0.893 ± 0.25 0.662 ± 0.29 0.566 ± 0.28 0.488 ± 0.27
The bold values indicate maximal metric value between the three baseline methods.
random. This ‘NR’ set had 1220 seed articles (‘NR1220’)
in total, less than the total number of unique participants
due to aforementioned exclusions.
Here, we have collectively defined candidate articles
marked as ‘somewhat-relevant’ or ‘irrelevant’ as negative
samples, with those marked as ‘relevant’ defined as positive
samples. This was to challenge the three baseline methods
and allow the measurement of their performance according
to binary classification. For all statistical testing we used the
Wilcoxon signed-rank test (75) implemented by the SciPy
(38) library.
Consistency between all and non-redundant sets
Table 2 compares the performance of the three baseline
methods within the ‘ALL2233’ and ‘NR1220’ sets. The
table shows that the three methods all had quite similar
performances, with TF-IDF having the slightest edge in
all metrics except precision @ 20. Moreover, the method
performance trend was shared between the ‘ALL2233’ and
‘NR1220’ sets, suggesting that participants with multiple
seed article annotations have not detectably biased the
overall result. This is likely due to the majority of all
unique participants submitting annotations for a single seed
article only. Another interesting observation is that PMRA
produced the most candidate articles marked as relevant
(indicated by average precision @ 20), but seemed to have
difficulty ranking these extra positive samples towards the
top of the result list.
Statistical P-values from Wilcoxon signed-rank tests are
given in Table 3. In both the ‘ALL2233’ and ‘NR1220’
sets, TF-IDF was significantly higher than PMRA with P-
values less than 0.05 for MCC, AUC, MRR and P@5.
For the ‘ALL2233’ set, BM25 was also significantly higher
than PMRA in terms of MCC and AUC; however, in the
‘NR1220’ only MCC is significant. In all cases there was no
significant difference in eitherMCC or AUC between BM25
and TF-IDF. However TF-IDF did significantly outperform
BM25 in terms of P@5. These results suggest that out of
the three baseline methods, TF-IDF was most effective at
ranking relevant candidate articles highly.
Consistency between author and non-author
annotators
As previously mentioned, according to author name
matches, the majority (91%) of our annotated seed articles
were provided by one of the respective authors. Here
we investigate whether method performance is affected
considering annotations given by non-authors. These non-
author annotators may have more general knowledge and
not be biased by a close-up view of their given field like
an author could be, potentially providing a more objective
assessment.
A total of 181 seed articles were identified to have been
annotated by a non-author (anonymous annotations were
not included), submitted by 73 unique annotators. These
articles were split into respective ‘ALL’ and ‘NR’ subsets
accordingly. Table 4 shows method performances, which
we are comparing to results presented in Table 2.A differing
trend in method preference can be observed within the
‘ALL’ set; however, measured performance and deviation
of performance between methods is comparable. Within
the ‘NR’ set, both method performance and preference
is almost identical, although according to the precision
measures the methods seem to have fared slightly better.
Overall, these results suggest that there is no significant
difference between annotations contributed by annotators
who authored the seed article versus external annotators
who did not author the seed article.
Consistency among different experience levels
Table 5 shows method performance on the ‘NR1220’ set
broken down by annotator experience level. Similarly to
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Table 3. Wilcoxon signed-rank test P-values between the PMRA, BM25 and TF-IDFmethods for the overall evaluation set. ‘ALL’
includes all seed articles from all participants, and ‘NR’ includes only one seed article from each participant, corresponding
to the ‘ALL2233’ and ‘NR1220’ sets, respectively. Metrics include MCC, AUC (ROC), MRR and P@N.
MCC AUC MRR P@5 P@10 P@20
ALL PMRA vs BM25 0.00700 0.02137 0.15841 0.07316 0.65928 0.07093
PMRA vs TFIDF 0.00727 0.01686 0.00074 0.00012 0.18130 0.71967
BM25 vs TFIDF 0.84588 0.83891 0.01023 0.00912 0.04617 0.01502
NR PMRA vs BM25 0.01985 0.11524 0.23883 0.41124 0.54669 0.04575
PMRA vs TFIDF 0.00015 0.00263 0.01043 0.00121 0.33197 0.81799
BM25 vs TFIDF 0.08311 0.08005 0.06478 0.00134 0.05845 0.05030
The bold values indicate P-values <0.05.
Table 4. Non-author annotator evaluation set performance results for the PMRA, BM25 and TF-IDF methods. ‘ALL’ includes
all seed articles in the set, and ‘NR’ includes only one seed article from each unique annotator in the set. Performance was
measured using MCC, AUC (ROC), MRR and P@N, given as (mean ± stdev).
# MCC AUC MRR P@5 P@10 P@20
ALL PMRA 181 0.477 ± 0.20 0.670 ± 0.16 0.878 ± 0.25 0.676 ± 0.27 0.599 ± 0.25 0.530 ± 0.25
BM25 0.482 ± 0.22 0.670 ± 0.18 0.857 ± 0.28 0.663 ± 0.30 0.593 ± 0.29 0.524 ± 0.27
TFIDF 0.468 ± 0.22 0.655 ± 0.19 0.876 ± 0.26 0.676 ± 0.30 0.598 ± 0.29 0.539 ± 0.29
NR PMRA 73 0.469 ± 0.19 0.666 ± 0.17 0.872 ± 0.26 0.671 ± 0.26 0.595 ± 0.24 0.516 ± 0.25
BM25 0.495 ± 0.21 0.675 ± 0.18 0.884 ± 0.27 0.707 ± 0.30 0.619 ± 0.29 0.540 ± 0.27
TFIDF 0.501 ± 0.21 0.684 ± 0.18 0.902 ± 0.24 0.712 ± 0.30 0.632 ± 0.29 0.553 ± 0.29
The bold values indicate maximal metric value between the three baseline methods.
Table 5. Detailed performance results of the ‘NR1220’ evaluation set broken down by participant experience levels for the
PMRA,BM25 and TF-IDF methods. Metrics include MCC, AUC (ROC), MRR and P@N, given as (mean ± stdev).
# MCC AUC MRR P@5 P@10 P@20
PhD (>10 years) PMRA 473 0.483 ± 0.22 0.663 ± 0.19 0.891 ± 0.26 0.649 ± 0.30 0.575 ± 0.28 0.505 ± 0.28
BM25 0.509 ± 0.23 0.684 ± 0.19 0.885 ± 0.25 0.657 ± 0.29 0.578 ± 0.28 0.501 ± 0.27
TFIDF 0.505 ± 0.23 0.684 ± 0.18 0.894 ± 0.24 0.671 ± 0.29 0.580 ± 0.28 0.503 ± 0.28
PhD (5–10 years) PMRA 189 0.493 ± 0.23 0.670 ± 0.20 0.855 ± 0.27 0.637 ± 0.29 0.574 ± 0.28 0.499 ± 0.26
BM25 0.495 ± 0.22 0.670 ± 0.19 0.862 ± 0.27 0.640 ± 0.29 0.561 ± 0.27 0.484 ± 0.25
TFIDF 0.513 ± 0.23 0.687 ± 0.19 0.880 ± 0.24 0.661 ± 0.27 0.565 ± 0.28 0.488 ± 0.27
PhD (<5 years) PMRA 192 0.473 ± 0.23 0.666 ± 0.19 0.860 ± 0.28 0.655 ± 0.30 0.579 ± 0.29 0.506 ± 0.27
BM25 0.491 ± 0.21 0.677 ± 0.17 0.899 ± 0.24 0.662 ± 0.29 0.578 ± 0.27 0.506 ± 0.26
TFIDF 0.519 ± 0.22 0.683 ± 0.19 0.924 ± 0.22 0.694 ± 0.29 0.585 ± 0.27 0.515 ± 0.27
PhD (student) PMRA 188 0.479 ± 0.22 0.669 ± 0.17 0.857 ± 0.26 0.620 ± 0.28 0.545 ± 0.26 0.470 ± 0.26
BM25 0.485 ± 0.19 0.659 ± 0.17 0.894 ± 0.24 0.629 ± 0.29 0.535 ± 0.27 0.452 ± 0.25
TFIDF 0.504 ± 0.21 0.683 ± 0.18 0.887 ± 0.26 0.644 ± 0.29 0.552 ± 0.27 0.468 ± 0.25
Other PMRA 178 0.464 ± 0.21 0.651 ± 0.18 0.842 ± 0.28 0.616 ± 0.28 0.532 ± 0.27 0.459 ± 0.25
BM25 0.496 ± 0.23 0.671 ± 0.19 0.841 ± 0.29 0.597 ± 0.29 0.510 ± 0.27 0.433 ± 0.25
TFIDF 0.523 ± 0.20 0.693 ± 0.18 0.874 ± 0.26 0.627 ± 0.28 0.525 ± 0.27 0.439 ± 0.25
The bold values indicate maximal metric value between the three baseline methods.
the baseline methods are again very close in performance,
with TF-IDF performing the best within each experience
group in terms of MCC, AUC, MRR and P@5 (except for
MCC and AUC in the ‘PhD-[>10y]’ group, andMRR in the
‘PhD-[student]’ group, where BM25 is best). Consistently
with the overall result, it can also be seen here that PMRA
produced the most candidate articles marked as relevant by
having the highest P@20 for each experience level except
for the ‘PhD-[<5y]’ group.
Figure 5 shows average AUC values given by PMRA,
BM25 and TF-IDF across annotators in different levels of
research experience (also shown are individual annotator
groups: A1, A2 and A3; see the following section). Here











castle user on 31 O
ctober 2019
Database, Vol. 2019, Article ID baz085 Page 11 of 66
Table 6. Wilcoxon signed-rank test P-values between the PMRA, BM25 and TF-IDF methods for the ‘NR1220’ evaluation set
broken down by participant experience level. Metrics include MCC, AUC (ROC), MRR and P@N.
MCC AUC MRR P@5 P@10 P@20
PhD (>10 years) PMRA vs BM25 0.09947 0.08577 0.73131 0.26733 0.49185 0.80459
PMRA vs TFIDF 0.14961 0.08633 0.80955 0.04125 0.41442 0.95105
BM25 vs TFIDF 0.91288 0.91259 0.46470 0.15842 0.59832 0.31508
PhD (5–10 years) PMRA vs BM25 0.91613 0.96776 0.75115 0.57120 0.62401 0.26477
PMRA vs TFIDF 0.67782 0.75515 0.35483 0.22400 0.93127 0.42470
BM25 vs TFIDF 0.63916 0.49584 0.34198 0.24906 0.52570 0.82280
PhD (<5 years) PMRA vs BM25 0.44472 0.78528 0.07519 0.78676 0.97772 0.71899
PMRA vs TFIDF 0.01568 0.11687 0.01056 0.03357 0.66985 0.31110
BM25 vs TFIDF 0.16426 0.66017 0.17176 0.00921 0.88387 0.48275
PhD (student) PMRA vs BM25 0.30311 0.87772 0.07136 0.35153 0.31363 0.14597
PMRA vs TFIDF 0.10552 0.26117 0.22179 0.21592 0.47528 0.99855
BM25 vs TFIDF 0.48173 0.08897 0.66555 0.85557 0.11509 0.05989
Other PMRA vs BM25 0.12823 0.21695 0.98643 0.15593 0.30027 0.01592
PMRA vs TFIDF 0.00165 0.05235 0.23290 0.73095 0.92710 0.30452
BM25 vs TFIDF 0.03934 0.10300 0.13172 0.03291 0.13125 0.60436
The bold values indicate P-values <0.05.
Figure 5. Method performance in terms of average AUC (ROC) for
PMRA, BM25 and TF-IDF on the ‘NR1220’ set across experience levels
within annotators and across three individual annotators (A1, A2 and
A3). Error bars represent standard deviation.
difference was observed between AUC values of the three
methods among different levels of experience. This is
echoed by P-values of the distribution comparison using
Wilcoxon signed-rank tests presented in Table 6; unlike the
overall result, there are not many statistically significant
differences in performance between methods within the
experience groups.
Finally, although the overall average was nearly identical
among annotators with different experience levels, fluc-
tuations around the average (standard deviations around
0.2) were quite substantial. This large fluctuation, however,
may not have been caused by individuals’ subjective opin-
ions. This is explored further with the assessment of single
participants who annotated many seed articles in the next
section.
Consistency within individual annotators
As some dedicated contributors had annotated a large
number of seed articles, we were able to assess method per-
formance within these groups. Table 7 presents the results
for the three largest groups, ‘A1’, ‘A2’ and ‘A3’ that had 92,
55 and 49 seed articles, respectively. In fact, these groups
appeared to also exhibit a similar level of fluctuation as
observed in the results for both the overall and divided by
experience sets. Thus, it is hypothesized that the observed
fluctuation could have been a result of a small number of
candidate article samples (20) per seed article per method
for calculating the variousmeasures or it could be attributed
to true differences in the ability to rank candidate articles,
i.e. that the three methods rank candidate articles better for
some seed articles than others.
Additionally, as method performance is again quite close
overall, some noise appeared to exist regarding the pre-
ferred method within these individual annotator groups. It
could be argued that ‘A1’ prefers BM25, ‘A2’ prefers TF-
IDF and ‘A3’ prefers PMRA. Furthermore, precision-based
metrics for ‘A1’ demonstrated fluctuation of ‘difficulty’,
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Table 7. Performance results of the three largest single-annotator sets for the PMRA, BM25 and TF-IDF methods. Metrics
include MCC, AUC (ROC), MRR and P@N, given as (mean ± stdev).
# MCC AUC MRR P@5 P@10 P@20
A1 BM25 92 0.610 ± 0.25 0.771 ± 0.19 0.740 ± 0.34 0.335 ± 0.19 0.226 ± 0.13 0.150 ± 0.09
PMRA 0.580 ± 0.26 0.728 ± 0.23 0.726 ± 0.35 0.313 ± 0.19 0.212 ± 0.11 0.149 ± 0.08
TFIDF 0.601 ± 0.27 0.752 ± 0.21 0.735 ± 0.35 0.337 ± 0.23 0.220 ± 0.13 0.155 ± 0.09
A2 BM25 55 0.538 ± 0.23 0.710 ± 0.19 0.882 ± 0.24 0.611 ± 0.29 0.498 ± 0.29 0.408 ± 0.27
PMRA 0.547 ± 0.17 0.699 ± 0.15 0.892 ± 0.24 0.553 ± 0.28 0.420 ± 0.24 0.342 ± 0.22
TFIDF 0.564 ± 0.20 0.729 ± 0.15 0.900 ± 0.25 0.615 ± 0.30 0.480 ± 0.28 0.377 ± 0.26
A3 BM25 49 0.550 ± 0.25 0.733 ± 0.18 0.966 ± 0.14 0.780 ± 0.22 0.698 ± 0.26 0.627 ± 0.28
PMRA 0.561 ± 0.25 0.732 ± 0.19 0.944 ± 0.17 0.788 ± 0.24 0.718 ± 0.24 0.614 ± 0.28
TFIDF 0.504 ± 0.25 0.697 ± 0.20 0.922 ± 0.20 0.710 ± 0.26 0.659 ± 0.29 0.605 ± 0.31
The bold values indicate maximal metric value between the three baseline methods.
Figure 6. Method performance in terms of AUC (ROC) for PMRA,
BM25 and TF-IDF across eight different research areas:Mice (‘D051379’),
Molecular models (‘D008958’), Protein binding (‘D011485’), Algorithms
(‘D000465’), Mutation (‘D009154’), Protein conformation (‘D011487’),
Computational biology (‘D019295’) and Biological models (‘D008954’).
Bars correspond to number of seed articles in the topic area, whereas
lines indicate method performance according to AUC values. Error bars
represent standard deviation.
the number of ‘positive’ annotations per seed article. For
example, a P@20 of around 0.1 means that on average
each method was trying to rank 2 relevant articles higher
than 18 irrelevant articles that must have also had large
content-based similarity of some form allowing their initial
detection by the baseline methods. In contrast, ‘A2’ and
‘A3’ were relatively easier, especially considering the MRR
value close to 1, meaning that on average the top result was
actually relevant.
Consistency among different research ﬁelds
Here, we assessed performance consistency across different
research topics, defined by MeSH descriptors associated
with each seed article (if any). Articles that shared a
MeSH descriptor were clustered accordingly. The eight
largest clusters were evaluated, Figure 6 shows method
AUC performance within these clusters (lines and error
bars of standard deviation corresponding to right y-
axis), and the number of seed articles within each cluster
(bars corresponding to left y-axis). The identified topics
include Mice (‘D051379’), Molecular Models (‘D008958’),
Protein Binding (‘D011485’), Algorithms (‘D000465’),
Mutation (‘D009154’), Protein Conformation (‘D011487’),
Computational Biology (‘D019295’) and BiologicalModels
(‘D008954’). Each topic was represented fairly equally,
where the range of seed articles per topic was between 20
and 30.No significant performance deviation was apparent
among the research topics.
Consistency of annotation for articles labelled by
multiple annotators
A more direct assessment of consistency is to examine the
same document pairs annotated by different contributors,
using the ‘D154’ set. These contributions covered a total
of 74 unique articles. However, 32 articles were removed
due to duplicate submitted annotations from a single par-
ticipant (i.e. the same participant contributed annotations
more than once for the same seed article). Subsequently
excluded were two articles that were annotated by three
participants. In total, 40 unique articles remained in this
consistency set (80 of 154 contributions; each article here
was annotated by exactly two unique participants).
We measured the agreement by first collapsing ternary
class annotations into their binary class equivalents. Next
the Jaccard index (48) was calculated, defined as the inter-
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Figure 7. Agreement between different annotators for the same seed article using Jaccard Index shown as average (left) and distribution (right).
The box on the left represents quartiles with the median as the middle line. The dashed line on the right is the average agreement value.
section size of the same negative annotations divided by the
union size of all annotations. The Jaccard index distribution
can be seen in Figure 7, where the overall trend was found
to indicate strong consistency, having only 3 out of the
40 cases below 50% agreement. The average annotation
consistency was 75%. In one of the low-agreement cases,
we contacted the original contributors and found that one
annotator defined relevance by ‘AND’ (satisfaction of all
topic keywords), whereas the other by ‘OR’ (as long as it
contained one essential topic keyword). Nevertheless, there
was high consistency observed among the majority of dual-
annotated document pairs.
Consistency regarding duration of time spent for
annotations
The duration of time a participant spent annotating seed
articles was an additional aspect we tested for consistency.
This duration was estimated from the time of loading the
first page of results to the time of submission. As this time
was estimated and is likely to contain a small degree of error
due to noise in the logs, we restricted the duration of time
spent to between 2 and 120 min.
Figure 8 demonstrates method performance as a func-
tion of time spent on annotations for the ‘NR1220’ set. Bin
sizes (bars corresponding to left y-axis) and method perfor-
mances (lines and error bars of standard deviation with
square, circle and diamond markers for PMRA, BM25 and
TF-IDF, respectively corresponding to right y-axis) are indi-
cated.As the majority of annotations were submitted within
17 min (75%), to equalize bin size as much as possi-
Figure 8. Method performance as a function of annotation time spent
for the ‘NR1220’ evaluation set; the x-axis is binned time-spent in
minutes; the vertical bars corresponding to the left y-axis is the number
of seed articles per bin; the lines corresponding to the right y-axis show
average AUC (ROC) per bin for the PMRA, BM25 and TF-IDF methods,
respectively.
ble, bin intervals had to be varied across the x-axis (they
are not uniformly sized). There was no obvious associa-
tion observed between time spent on annotations and the
resultant method performance, indicating that there was
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Figure 9. Distribution of score thresholds yielding the highest MCC
value per seed article for the PMRA, BM25 and TF-IDF methods.
Consistency among thresholds for binary
classiﬁcation
Distinguishing positives from negatives requires a threshold
for the similarity score calculated by PMRA, BM25 or
TF-IDF. An ideal method should have the same threshold
for different seed articles regardless of research field and
abstract/title length. This would be beneficial to real-world
recommender systems by enabling a dynamic number of
articles deemed as relevant to be presented to the user rather
than the traditional approach of delivering a fixed number
of recommendations.
We analyzed the distribution of method score thresholds
in Figure 9. Raw method scores were first normalized using
the min-max method and then divided into 50 equally sized
bins. All of the methods’ threshold distributions were found
to be relatively centralized around their respective peaks;
however, PMRA clearly compared well to other methods
and had the most stable cut-off values with a standard
deviation of 0.06, compared to 0.08 and 0.09 for BM25 and
TF-IDF, respectively. This finding suggests the possibility of
setting a unified relevance cut-off.
Differences between the three methods
Figure 10 examines true relevant articles uniquely con-
tributed by each method (PMRA, BM25 or TF-IDF in the
top panel) and the overlaps among them. In most cases
PMRA output the largest proportion of relevant articles
(avg. 17%) that were not given by either BM25 or TF-IDF
(additionally highlighted by the average P@20 for PMRA).
In contrast, BM25 had the lowest contribution of unique
Figure 10. Consistency and difference among three methods: PMRA,
BM25 and TF-IDF; upper—unique relevant recommendations given by
each method; lower—overlap of relevant recommendations between
methods. Boxes represent the quartiles; middle lines are the median.
relevant recommendations (avg. 8%).Meanwhile, the over-
lap among all methods was low with the highest overlap
between BM25 and TF-IDF at 32% on average. Thus,
clearly none of these baseline methods could provide com-
plete coverage of all relevant articles. Relatively few recom-
mendations were shared by the three methods, indicating
that is likely possible to establish a well-performing hybrid
method that would aggregate outputs of multiple methods.
Data Records
A complete dump of collected annotation data as at 27
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dataset is released without copyright, available at https://
figshare.com/projects/RELISH-DB/60095, under the CC0
license. All data records were stripped of personally iden-
tifiable information and then converted to JSON format
(41). Record fields include a unique identifier (‘uid’), Pub-
MedID of the seed article (‘pmi’), annotator experience
level (‘experience’), whether the annotator was an anony-
mous or registered user (‘is_anonymous’) and annotator
response (‘response’) containing the lists of candidate article
PubMedIDs corresponding to the assigned degree of rele-
vance (i.e. one of ‘relevant’, ‘partial’ (somewhat-relevant) or
‘irrelevant’).
Usage Notes
To make RELISH collections useful for future method
developers, we have established a data server at https://
relishdb.ict.griffith.edu.au. This data server has three mod-
ules for data annotation, data retrieval and method testing.
Data annotation: data annotation functions exactly as
the APSE server. As shown in Figure 1, users can search
for publications related to any article of interest, with
the option to voluntarily annotate article relevance.
New submissions will be automatically saved for inclu-
sion in the next database version.
Data retrieval: we have made available several pre-built
datasets (the evaluation sets within this work) on our
data server. These include the complete versions of the
‘ALL2233’ and ‘NR1220’ sets, as well as copies of
these sets broken down by annotator experience level. In
addition, the three single-annotator sets (‘A1’, ‘A2’ and
‘A3’) are also available. Furthermore, we also provided
an option to allow users to generate a dataset according
to various pre-defined parameters (dataset size, expe-
rience level, single seed article or multiple seed article
annotators and cut-offs for the number of candidate
articles labelled as relevant or irrelevant per seed article).
As shown in Figure 11, pre-compiled datasets can be
inspected by starting at (1). Alternatively, user-defined
datasets may be generated by starting at (2). After
generating a new dataset, or clicking on an existing one,
the dataset view page will be displayed as shown in stage
(3). Here, dataset details including size, number of posi-
tive and negative pairs, and any custom parameters that
were set will be given. For each dataset, we make avail-
able the respective subsets of article metadata, anno-
tation data and an example result file in the format
the automatic evaluation will accept, as shown in stage
(4). The metadata includes the PubMedID, title and
abstract for each article involved in the dataset. Because
we are using publicly licensed PubMed metadata, we
allow for direct download of this metadata in JSON
format (41). Relevance data are provided in TREC
relevance format (56). Method developers can divide
downloaded datasets into training and independent test
sets according to their own specific needs.
Method testing: to facilitate comparison and avoid
overtraining, we set aside a blind-test set for critical
assessment of method performance. This selection
of 400 randomly selected NR seed articles have
their annotation data withheld from the rest of the
database. The dataset has two variants (‘BT1’ where
partially relevant articles are considered as ‘positive’
samples, whereas in ‘BT2’ partially relevant articles
are considered as ‘negative’ samples). Baseline method
performances for this set are shown in Table 8. Overall,
the results are consistent with what was observed for the
complete dataset. We envision that method developers
can download pre-built or user-defined datasets for
training and independent tests. Subsequently, they can
download ‘BT1’ or ‘BT2’ to provide additional tests
by submitting the result file in TREC result format
(61) as shown in stage (5) of Figure 11. Evaluations
will be automatically executed and a list of recorded
evaluations for the dataset will be shown in stage (6).
After uploading a result file for a new evaluation,
or clicking on an existing evaluation in the list, the
evaluation results will be displayed: firstly, a summary
of metrics over the dataset as a whole is given by stage
(7) and secondly, the metrics are broken down into a
per seed article query basis for inspection in stage (8).
Motivation and Limitations
Many users, both expert and non-expert, require literature
searching for various purposes. Generally, the information
need revolves around knowledge expansion of a topic;
whether the goal is to find pertinent supporting material
to solidify insight or to broaden their vision by locating
different aspects, of a particular claim, idea or field of
research.
Users most commonly rely on manual keyword search-
ing methods to serve their needs (19, 21, 31, 37, 70).
While it is recognized that this type of searching tools
are indispensable (19); a major concern, one that the use
case of our work attempts to address, is how users can
be easily dissatisfied by the results given by this proce-
dure. For example, produced results largely depend on,
and may substantially vary, based on how well the user is
able to ‘fine-tune’ their queries delivered to the searching
system (31). Moreover, the conversion process between an
information need to an effective query is often a potential
source of difficulty (19, 37). While search engines often
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Figure 11. An overview of the database retrieval and evaluation process: (1) use existing datasets—both pre-built and user-generated; (2) create
custom datasets—allows for user-deﬁned dataset construction by tuning dataset generation parameters; (3) dataset details—shows the size, number
of positive and negative pairs and any custom parameters used to generate; (4) dataset article data—allows user download of (a) raw articlemetadata
(id, title and abstract) (b) annotation data and (c) sample result ﬁle for evaluation function; (5) result ﬁle upload—allows input of result ﬁles for
automatic performance assessment; (6) uploaded evaluations—results of uploaded result ﬁle evaluations for the respective dataset will be presented
here; (7) overall evaluation view—provides a performance summary of the dataset as a whole; (8) detailed evaluation view—performance details
are broken down on a per-query basis.
Table 8. Performance results of the blind test set of 400 randomly selected articles for the PMRA, BM25 and TF-IDF methods.
‘BT1’ considered partially relevant articles as ‘positive’, and ‘BT2’ considered partially relevant articles as ‘negative’. Metrics
include MCC, AUC (ROC), MRR and P@N, given as (mean ± stdev).
MCC AUC MRR P@5 P@10 P@20
BT1 BM25 0.489 ± 0.25 0.680 ± 0.20 0.964 ± 0.15 0.857 ± 0.20 0.807 ± 0.20 0.748 ± 0.20
PMRA 0.497 ± 0.24 0.694 ± 0.19 0.967 ± 0.13 0.871 ± 0.19 0.828 ± 0.19 0.763 ± 0.19
TFIDF 0.512 ± 0.24 0.699 ± 0.19 0.981 ± 0.10 0.875 ± 0.18 0.821 ± 0.19 0.759 ± 0.19
BT2 BM25 0.495 ± 0.19 0.665 ± 0.17 0.856 ± 0.29 0.582 ± 0.30 0.482 ± 0.25 0.396 ± 0.21
PMRA 0.497 ± 0.20 0.676 ± 0.17 0.853 ± 0.28 0.605 ± 0.29 0.506 ± 0.25 0.413 ± 0.21
TFIDF 0.493 ± 0.19 0.670 ± 0.16 0.877 ± 0.26 0.594 ± 0.27 0.492 ± 0.23 0.404 ± 0.21
The bold values indicate maximal metric value between the three baseline methods.
user unfriendliness of these syntaxes diminish their use to
a negligible rate (69). Ultimately, users’ needs are met in a
‘hit-or-miss’ basis (2, 36, 69) within this approach.
Here, the use case of our work falls into the ‘recom-
mendation’ sub-field of literature search. Specifically, we
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Considering the rate of literature growth and the associ-
ated ‘information overload’ for users, remedial approaches
like recommender systems have been proposed to tackle
the difficulty and time burden of keeping track of the
most promising and relevant studies (12, 30). While at
the present time recommender systems may be considered
an uncommon use case for biomedical literature search
systems, such as PubMed, there has been interest shown in
the development of additional biomedical searching tools
(53), including systems that allow identification of similar
publications (18, 20, 26, 60, 76). Moreover, the frequency
of their use depends strongly on the accuracy of recommen-
dations. It is the developers of these types of recommen-
dation systems we anticipate to benefit the most from our
database.
This work is not the first to propose the use of a seed
article (manuscript) as a query instead of keywords (10, 27,
37, 46, 55, 71). As stated in (31), the following scenarios
illustrate potential applications of a system built upon this
ideology: editors or reviewers wishing to explore a subject
matter of which is not their specialty (e.g. to find other
potential peer reviewers), researchers simply wishing to find
related studies to a paper of interest (e.g. for the purpose of
locating citations or venues for their work), researchers who
are pursuing a new area of which they have little existing
knowledge (e.g. a student following up on a paper given by
their supervisor) and researchers wishing to keep up with
latest developments in their field based on their previous
publications.
Finally, we must stress that the basis of our use case here
is a complementary alternative to keyword search, it is not
intended as a replacement. An accurate keyword-less rec-
ommendation system is sure to benefit both expert and non-
expert users, especially in this era of information overload.
In addition, this is more than a database exclusively for
seed article-based search. It can be used to train keywords
or sentence-based search by examining if keywords or the
title from one article would automatically lead to the other
articles. That is, a method can be trained for title/sentence-
based and title/abstract based search on this benchmark.
Discussion
Our work represents a community-wide effort to establish a
database of document relevance that is suitable for machine
learning. It should be noted that our APSE system facili-
tating the annotation process was not intended as a stand-
alone search engine. Rather, it was developed and employed
exclusively for data collection. Nevertheless, using three
different methods appeared to provide a more complete
search compared to systems powered by a single technique
such as TF-IDF in JANE (67) or PMRA in PubMed (49).
This is consistent with comments from many users who
found interesting articles previously unknown to them.
More than 1500 scientists around the world participated
in the RELISH consortium and annotated the relevance
for over 180,000 document pairs that represent diverse
research fields, covering 76% of all PubMedMeSH descrip-
tors without clear bias (Figure 3). These annotations are
of high quality as more than 90% of the article pairs
were annotated by original authors and 63% by scientists
with 5 or more years research experience post-PhD. While
the majority annotated a single seed article, a few ded-
icated researchers annotated more than 50 seed articles,
and some independently annotated the same seed articles.
Together, the resulting dataset provides the largest manually
annotated benchmark for detecting document similarity in
biomedical literature search.
A number of potential systematic biases were consid-
ered during the construction of this database. Potentially
affected aspects of our methodology primarily include how
the documents presented to annotators were selected and
how annotators themselves were selected. We discuss here
the biases we were able to identify and explain the rationale
behind how they were dealt with.
Inherent selection biases could be argued regarding the
baseline methods used to generate the sets of documents
for annotation. Firstly, since only the top 20 non-redundant
documents from eachmethodwere presented to annotators,
we have necessarily excluded potentially related articles
with lower similarity scores from this pool. We could have
taken more results from a single method, but then bias
towards that single method would have been introduced.
Additionally, we chose to take this number of results from
each method to reduce the burden on annotator’s partic-
ipation time, as we appreciate that volunteered time to
contribute is valuable. Secondly, as the baseline methods
rely exclusively on exact term matches to generate respec-
tive similarity scores, it is possible that semantically related
documents are missing from this pool. Although there was
no scalable solution present to circumvent this, we feel it
should be mentioned here.
Potentially subjective bias is a major concern affecting
document relevance manually annotated by such a diverse
group of scientists. This could be in terms of a biased
consideration of recommended documents according to the
annotator’s close-up view of their given field as opposed to
the more objective consideration annotators with general
knowledge could have. We opted to use authors of their
own papers as relevance judges to increase participation
rate, the effort required from participants was again con-
sidered here. This is because our goal for this benchmark
was to capture sub-field similarity such that articles marked
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originating seed article. This task requires highly specialized
experts in respective sub-fields to make that determination.
In other words, the more sub-field experience of an annota-
tor, the more accurate annotations will be made. Although
non-PhD researchers are underrepresented in their par-
ticipation of database construction, it will not affect the
overall accuracy of annotations as we have demonstrated
that there is no bias according to the experience level of
annotators and across different fields of researchers. In
fact, using expert annotations will ensure the production
of relevant articles for all non-PhD researchers, clinicians
and the general public in their searches.
If a subjective bias exists, one would expect that the
performance of the three baseline methods (PMRA, BM25
and TF-IDF) would have certain systematic trends. We
showed that method performances were nearly the same
across different annotator experience levels (Figure 5), dif-
ferent research topics (Figure 6) and different durations of
time spent annotating (Figure 8) and whether annotators
evaluated articles they authored or not (Tables 2 and 4).
Although the magnitude of the performance fluctuation
was large between different annotators, the samemagnitude
of fluctuation was observed within individual annotators
(Figure 5), suggesting that the source of fluctuation likely
was small size of samples (20 per seed article for each
method) and/or true differences in difficulty (i.e. some seed
articles are easier to find relevant articles for than others).
More importantly, examining same document–document
pairs annotated by different researchers indicated a high
average consistency of 75% (Figure 7). Furthermore, high
consistency in the dataset was also suggested by the rela-
tively narrow distribution of thresholds that were used to
maximize the MCC for each seed article (Figure 9). This
indicated that relevance can be defined across different
experience levels or research fields. The results collectively
indicate that despite the presence of any subjective bias, a
consensus exists regarding what is actually relevant litera-
ture for the majority of researchers, despite differences in
research areas and experience levels.
High-quality data collected by the RELISH consortium
offered an unprecedented opportunity to compare the three
baseline methods (PMRA, BM25 and TF-IDF). Somewhat
surprisingly, all three methods performed similarly, with
TF-IDF presenting a slight edge. Our finding is somewhat
different from previous studies (22, 51, 68) where the classic
TF-IDF was often considered inferior to methods developed
afterwards. This result highlights the importance of having
a large benchmark dataset. Moreover, all three methods
evaluated here performed only moderately well with an
average AUC of around 0.7 and average MCC of around
0.5. In addition, different methods did capture different sets
of relevant articles (Figure 10). This further indicates the
necessity of large benchmark evaluation datasets, signifi-
cant room exists for improving literature search with future
method development.
Encouraging method development was the principal
motivation behind the assembly of this database. A recent
survey of research paper recommendation systems revealed
the urgent need for a common evaluation framework (4), as
current method evaluation results are rarely reproducible
(3). This work was inspired by large human-annotated
databases like ImageNet (17), where labelled images have
promoted method development and helped to revolutionize
object detection and image classification (45).Our database
should allow novel methods to be developed based on
modern deep machine learning techniques to address
the major deficiencies of current methods. Additionally,
the benchmark datasets as a result of our database
will enable objective comparison between old and new
methods, increasing the uptake of newer methods and their
translation into practice. To assist unbiased evaluation,
we have made the RELISH database freely accessible to
the academic community (released under the CC0 license).
Furthermore, we set aside 400 × 60 document–document
pairs for blind prediction using the automatic evaluation by
our database server at https://relishdb.ict.griffith.edu.au.
We expect that dissemination of this manuscript will
attract more scientists to contribute more annotations.
A major struggle for us was participant recruitment,
the first phase of our recruitment strategy (internal
referrals, personal invitations, social media posts and a
correspondence letter) ultimately failed to attract enough
contributions to establish a meaningful dataset. Because
of this failure we reluctantly decided to proceed with
the second phase of sending direct emails. Although the
response rate was low (around 1%), it was good enough
to achieve the sizeable database we have now. Our server
will continue to collect annotations. We hope to publish
the next version of the database with at least double the
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CHULiège, Liège, Belgium;
203. MPBA, Fondazione Bruno Kessler, Trento,
Italy;
204. Department of Neurobiology, Hokkaido University
Graduate School of Medicine, Sapporo, Japan;
205. Oncology, University of Leuven, Belgium;
206. Department of Mathematical Sciences, Chalmers
University of Technology, Göteborg, Sweden;
207. Department of Neurology, Radboud University
Medical Center, Nijmegen, Netherlands;
208. School of Information Technology and Mathemat-
ical Sciences, University of South Australia, Adelaide, SA,
Australia;
209. Department of Computational Biology, Bio-Thera
Solutions Ltd., Guangzhou, China;
210. Otolaryngology, Instituto de Investigación Biosan-
itario de Granada IBS.Granada, Spain;
211. School of Molecular and Life Sciences, Curtin
University, Perth, WA, Australia;
212. Institute of Cellular Medicine, Newcastle Univer-
sity, Newcastle upon Tyne, UK;
213. Institute of Pharm. Biology/DCAL, Goethe Univer-
sity, Frankfurt, Germany;
214.UMR5246 Institut de Chimie et BiochimieMolécu-
laires et Supramoléculaires (ICBMS), Université de Lyon,
France;
215. Department of Genomes and Genetics, Institut
Pasteur, Paris, France;
216. Pharmacology, University of Valencia, Spain;
217. Research Centre for Olive, Citrus and Tree Fruit,
Council for Agricultural Research and Economics, Caserta,
Italy;
218. Preclinical Pharmacology and In Vitro Toxicol-
ogy, Fraunhofer Institute for Toxicology and Experimental
Medicine (ITEM), Hannover, Germany;
219. School of Medicine, University of Tasmania,
Hobart, TAS, Australia;
220. Oncology Lifecycle Management Department,
Chugai Pharmaceutical Co. Ltd, Tokyo, Japan;
221. Institute of Neurobiology, University of Lübeck,
Germany;
222. Neurology, New York University School of
Medicine, New York, NY, USA;
223. Department of Plant Pathology, University Putra
Malaysia, Seri Kembangan, Malaysia;
224. Biology, University of North Carolina at Chapel
Hill, NC, USA;
225. Faculty of Health Sciences,University of Southamp-
ton, UK;
226.Genetics and Immunology Research Group,Univer-
sity of the Highlands and Islands, Inverness, UK;
227. Institute of Pathology, University of Heidelberg,
Germany;
228. Department of Computational Biology,
Indraprastha Institute of Information Technology, New
Delhi, India;
229. School of Health and Life Sciences, Glasgow Cale-
donian University, Glasgow, UK;
230. Pharmacy and Biomolecular Sciences, Liverpool
John Moores University, Liverpool, UK;
231. Basic Research, Parkinson’s Institute and Clinical
Center, Sunnyvale, CA, USA;
232. Environmental Research and Innovation, Luxem-
bourg Institute of Science and Technology, Luxembourg;
233. School of Computing and Information Technology,
University of Wollongong, Wollongong, NSW, Australia;
234. Department of Biomedical Sciences and Human












castle user on 31 O
ctober 2019
Database, Vol. 2019, Article ID baz085 Page 39 of 66
235. College of Nursing and Health Sciences, Flinders
University, Adelaide, SA, Australia;
236. Molecular Medicine, University of South Florida,
Tampa, FL, USA;
237. Behavioral & Brain Sciences, The University of
Texas at Dallas, Richardson, TX, USA;
238. Zoology & Entomology, Rhodes University,
Grahamstown, South Africa;
239. Instituto de Higiene e Medicina Tropical, Universi-
dade NOVA de Lisboa, Portugal;
240. Institute of Microbiology, ETH Zurich,
Switzerland;
241. Immunohaematology, German Red Cross Blood
Service, Institute Ulm, Germany;
242. Institute of Advanced Biomedical Engineering and
Science, Tokyo Women’s Medical University, Tokyo, Japan;
243. Biological Sciences, University of Limerick, Ireland;
244. Department of Animal Science, McGill University,
Montreal, QC, Canada;
245. StatSol, Lübeck, Germany and School of Math-
ematics, Statistics and Computer Science, University of
KwaZulu-Natal, Pietermaritzburg, South Africa;
246. Institute of Systems Biology (INBIOSIS), Universiti
Kebangsaan Malaysia (UKM);
247. National Center for Complementary and Integra-
tive Health, National Institutes of Health, Bethesda, MD,
USA;
248. Family Medicine Research Division, University of
Kansas Medical Center, Kansas City, KS, USA;
249. Multimodal Molecular Biology, Institute of Molec-
ular and Cell Biology, Agency for Science, Technology and
Research (A*STAR), Singapore;
250. Department of Chronic Diseases, Metabolism and
Ageing, University of Leuven, Belgium;
251. International Iberian Nanotechnology Laboratory
(INL), Braga, Portugal;
252. Computing and Technology, Anglia Ruskin, Cam-
bridge, UK;
253. Structural Cell Biology, Max Planck Institute of
Biochemistry, Planegg, Germany;
254. Department of Computer Architecture and Tech-
nology, Universidad de Sevilla, Spain;
255. EBIO, University of Colorado, Boulder, CO, USA;
256. Cancer Sciences, University of Manchester, UK;
257. Research School of Population Health, The Aus-
tralian National University, Canberra, ACT, Australia;
258. Bio-systems, Singapore-MIT Alliance for Research
and Technology, Singapore;
259. Musculoskeletal Health and Ageing Research
Program, Mary MacKillop Institute for Health Research,
Australian Catholic University, Melbourne, VIC,
Australia;
260. General Surgery, St. Josef Hospital - Ruhr Univer-
sity Bochum, Germany;
261. College of Life Sciences, Northwest A&F Univer-
sity, Shaanxi, China;
262. Division of Plant Science, Research School of Biol-
ogy, The Australian National University, Canberra, ACT,
Australia;
263. Clinical and Nonclinical Research, Battelle,
Columbus, OH, USA;
264. Biological Sciences, Southern Methodist University,
Dallas, TX, USA;
265. Institute of Medical Mycology, Teikyo University,
Tokyo, Japan;
266. Bioinformatics, Tempus Labs, Chicago, IL, USA;
267. College of Biology, Hunan University, Changsha,
China;
268. Department of Infection, Immunity and Inflamma-
tion, Institut Cochin, Paris, France;
269. FutureNeuro Research Centre, Physiology &Med-
ical Physics, Royal College of Surgeons in Ireland, Dublin,
Ireland;
270. Gerontology Research Center, University of
Jyvaskyla, Finland;
271. Department of Anesthesiology, University of
Heidelberg, Germany;
272. Biology, Pennsylvania State University, PA, USA;
273. State Key Laboratory ofMicrobial Resources, Insti-
tute of Microbiology, Chinese Academy of Sciences, Beijing,
China;
274. School of Life Sciences, University of Science and
Technology of China, Anhui, China;
275. Animal Science, Michigan State University, East
Lansing, MI, USA;
276. Buffalo Neuroimaging Analysis Center, Depart-
ment of Neurology, Jacobs School ofMedicine and Biomed-
ical Sciences, University at Buffalo, State University of
New York, NY, USA;
277. Institute for Biological Sciences, University of
Rostock, Germany;
278. Environmental Research Institute, School of
Environment, South China Normal University, Guangzhou,
China;
279. Department of Veterinary Medicine, University of
Bari, Italy;
280. Primary and Community Care,Radboud University
Medical Center, Nijmegen, Netherlands;
281. EcoHealth Alliance, New York, NY, USA;
282. Cardiovascular Department, Mayo Clinic,
Rochester, MN, USA;
283.Department of Epidemiology, School ofMedicine in
Katowice, Medical University of Silesia, Katowice, Poland;
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285. Pharmaceutical Outcomes & Policy, University of
Florida College of Pharmacy, Gainesville, FL, USA;
286. Earth and Biological Science Directorate, Pacific
Northwest National Laboratory, Richland, WA, USA;
287. Centre for Discovery Brain Sciences, University of
Edinburgh, UK;
288. Department of Biomedical Informatics, Harvard
Medical School, Boston, MA, USA;
289. Radiology, University of Pennsylvania,
Philadelphia, PA, USA;
290. Biomedical Sciences - Personalized Medicine,
Asthma and Allergy unit, Humanitas University and
Research Hospital, Rozzano, Italy;
291. Department of Quantum Science, The Australian
National University, Canberra, ACT, Australia;
292. Ecological Genomics, University of Oldenburg,
Germany;
293. Paediatric Dentistry & Orthodontics, International
Medical University, Kuala Lumpur, Malaysia;
294. School of Nursing, University of Ottawa, ON,
Canada;
295. Department of Education Support,Maastricht Uni-
versity, Maastricht, Netherlands;
296. Mathematics, University of Manchester, UK;
297. School of Population Health Sciences, Faculty of
Life Sciences and Medicine, King’s College London, UK;
298. Institute of Health and Biomedical Innovation,
Queensland University of Technology, Brisbane, QLD,
Australia;
299. Epidemiology, Public Health School, Harbin Med-
ical University, Heilongjiang, China;
300. Department of Chemistry, UiT - The Arctic Univer-
sity of Norway, Tromsø, Norway;
301. Biological Statistics and Computational Biology,
Cornell University, Ithaca, NY, USA;
302. Shanghai Key Lab for Urban Ecological Process and
Eco-restoration, School of Ecological and Environmental
Sciences, East China Normal University, Shanghai, China;
303. Faculty of Biology, Johannes Gutenberg University,
Mainz, Germany;
304. Food Science,University ofMassachusetts Amherst,
MA, USA;
305. Complex Adaptive Traits Research Group, Max
Planck Institute for Terrestrial Microbiology, Marburg,
Germany;
306. Centre for Exercise and Rehabilitation Science,
NIHR Biomedical Research Centre - Respiratory, Leicester,
UK;
307. Section of Endocrinology, Department of Internal
Medicine, Yale University, New Haven, CT, USA;
308. Department of Biosciences, Sardar Patel University,
Gujarat, India;
309. Department of Applied Physics, The University of
Tokyo, Japan;
310. Cologne Excellence Cluster for Cellular Stress
Responses in Aging-Associated Diseases (CECAD), in
vivo Research Facility (ivRF), University of Cologne,
Germany;
311. Department of Public Health Science, National
Open University of Nigeria, Lagos, Nigeria;
312. Department of Radiology, University Hospital
Regensburg, Germany;
313. Geography, National University of Singapore;
314. College of Medicine, Alfaisal University, Riyadh,
Saudi Arabia;
315. Biomedical Genomics and Oncogenetics Research
Laboratory, Faculty of Sciences and Techniques of Tangier,
Abdelmalek Essaadi University, Morocco;
316. Exercise Biology Group, Faculty of Sport and
Health Sciences, Technical University of Munich, Germany;
317. Departamento de Psicoloxía Social, Básica e
Metodoloxía, Universidade de Santiago de Compostela,
Galiza, Spain;
318. Signal Processing Laboratory, Griffith University,
Brisbane, QLD, Australia;
319. Department of Neurology, Ghent University and
Ghent University Hospital, Belgium;
320. Faculty of Veterinary Medicine, Ghent University,
Merelbeke, Belgium;
321. Institute for Clinical and Translational Research,
Albert Einstein College of Medicine, New York City, NY,
USA;
322. Faculty of Medical Science, Anglia Ruskin Univer-
sity, Cambridge, UK;
323. College of Chemistry and Molecular Engineering,
Peking University, Beijing, China;
324. Department of Dermatology and Allergy, Herlev
and Gentofte Hospital, Hellerup, Denmark;
325. Medical Imaging and Nuclear Medicine, Lady
Cilento Children’s Hospital, Brisbane, QLD,
Australia;
326. Nursing and Reproductive Health, School of
Medicine and Allied Health Sciences, University of The
Gambia, Brikama, Gambia;
327.Woolcock Institute of Medical Research, University
of Sydney, NSW, Australia;
328. Computer Science,Wayne State University, Detroit,
MI, USA;
329. Otolaryngology, Aberdeen Royal Infirmary,
Aberdeen, Scotland;
330. Laboratory Medicine and Pathobiology, University
of Toronto, ON, Canada;
331. Institute of Ageing, The Chinese University of Hong
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332. Emergency Medicine, University of Nebraska Med-
ical Center, Omaha, NE, USA;
333. Pathology, University of Florida College of
Medicine, Gainesville, FL, USA;
334. Radiation Oncology,MD Anderson Cancer Center,
Houston, TX, USA;
335. Translational Research NTMS, University of Pisa,
Italy;
336. Clinical and Experimental Medicine,Magna Grecia
University, Catanzaro, Italy;
337. Pediatrics, Larner College of Medicine University
of Vermont, Burlington, VT, USA;
338. Diagnostic and Interventional Ultrasound, Sun
Yat-sen University Cancer Center, Guangzhou, China;
339. Institutes of Brain Science, Fudan University,
Shanghai, China;
340. College of Agronomy, Shanxi Agricultural Univer-
sity, Shanxi, China;
341. Institute of Medical Science, University of Toronto,
ON, Canada;
342. ARCPOH, University of Adelaide, SA, Australia;
343. Cardiology and Vascular Medicine, Faculty
of Medicine, Pelita Harapan University, Tangerang,
Indonesia;
344. Research Division, Institute of Mental Health,
Singapore;
345. MRC Clinical Trials Unit, University College
London, UK;
346. Department of Philosophy, Sociology, Education
and Applied Psychology (FISPPA), University of Padua,
Padova, Italy;
347. Department of Psychiatry and Psychotherapy,
University of Lübeck, Lübeck, Germany;
348. Center for Molecular Medicine, Dalian University
of Technology, Liaoning, China;
349. Reproductive Medicine, Tianjin United Family
Healthcare, Tianjin, China;
350. Departament d’Enginyeria Química Biològica i
Ambiental, Universitat Autònoma de Barcelona, Spain;
351. Department of Animal Science, Sao Paulo State
University (UNESP), Sao Paulo, Brazil;
352.Cancer Systems Biology, Institute of Computational
Biology, Helmholtz Zentrum München, Ingolstädter Land-
straße 1, D-85764, München, Germany;
353. Department of Cardiovascular Medicine, The Uni-
versity of Tokyo, Japan;
354. Veterinary Clinical, Sao Paulo State University,
Paulo, Brazil;
355. Institute of Biotechnology, Zhejiang University,
Hangzhou, Zhejiang, China;
356. Department of Molecular Biology and Genetics,
Aarhus University, Denmark;
357. Maternal and Fetal Health, St. Mary’s Hospital,
University of Manchester, UK;
358. Internal Medicine, University of New Mexico,
Albuquerque, NM, USA;
359. Division of Biomedical Statistics and Informatics,
Mayo Clinic, Jacksonville, FL, USA;
360. Plant Production, King Saud University, Riyadh,
Saudi Arabia;
361. Department of Molecular Biology, Institute of
Genetics and Animal Breeding of the Polish Academy of
Sciences;
362. Optometry and Vision Science, Queensland Univer-
sity of Technology, Brisbane, QLD, Australia;
363. School of Life Sciences, University of Nottingham,
UK;
364. Cancer Research Centre, Cancer Council Queens-
land, Brisbane, QLD, Australia;
365. Department of Chemistry, Umeå University, Umeå
Sweden;
366. Centre for Radiation, Chemical & Environmental
Hazards, Public Health England, Bristol, UK;
367. DISTABIF, Università della Campania ”L. Van-
vitelli”, Caserta, Italy;
368. Obstetrics and Gyanecology, Bartshealth, London,
UK;
369. GReD Laboratory, Université Clermont Auvergne,
Clermont-Ferrand, France;
370. INRA,Abeilles et Environnement, Avignon, France;
371. School of Public Health and Social Work, Queens-
land University of Technology, Brisbane, QLD,
Australia;
372. Psychiatry, University of Pennsylvania, Philadel-
phia, PA, USA;
373. Research Institute of Physiology and Basic
Medicine, Novosibirsk State University, Russia;
374. Department of Chemistry, University College
London, UK;
375. Animal, Plant and Soil Sciences, La Trobe Univer-
sity, Melbourne, VIC, Australia;
376. Epidemiology and Biostatistics, University of
Arizona, Tucson, AZ, USA;
377. ERIBA, University Medical Center Groningen,
University of Groningen, Netherlands;
378. Department of Radiation Physics, Institution
of Clinical Science, University of Gothenburg, Sweden;
379. Biochemistry and Molecular Biology, SUNY
Upstate Medical University, Syracuse, NY, USA;
380. Centro de Pesquisas Goncalo Moniz, Fundacao
Oswaldo Cruz, Bahia, Brazil;
381. Food, Water and Environmental Microbiology,
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382. Food Science, University of Otago, Dunedin,
New Zealand;
383. Biomedical Science, Florida Atlantic University,
Boca Raton, FL, USA;
384. Institute for Molecular Bioscience, The University
of Queensland, Brisbane, QLD, Australia;
385. Institute of Clinical Neurobiology, University Hos-
pital Würzburg, Germany;
386. Public Health, Institute of Tropical Medicine,
Antwerpen, Belgium;
387.Department of Rheumatology andClinical Immunol-
ogy, Faculty of Medicine, School of Health Sciences,
University of Thessaly, Larissa, Greece;
388. Department of Orthodontics and Pediatric Den-
tistry, UZB University Center for Dental Medicine, Univer-
sity of Basel, Switzerland;
389. Institut Systématique, Evolution, Biodiversité
(ISYEB), UMR 7205 MNHN-CNRS-Sorbonne Université-
EPHE, Museum National d’Histoire Naturelle, Paris,
France;
390. Institute for Advanced Bioscience, CNRS, France;
391. School of Molecular Sciences, The University of
Western Australia, Perth, WA, Australia;
392. Biochemistry and Microbiology, University of Fort
Hare, South Africa;
393. Physics, University Tübingen, Germany;
394. School of Environment and Science, Griffith Uni-
versity, Brisbane, QLD, Australia;
395. Statistics and StandardisedMethods, Philosophisch-
Theologische Hochschule Vallendar, Germany;
396. Life Sciences, Imperial College London, UK;
397. Adelaide Medical School, University of Adelaide,
SA, Australia;
398. Department of Pharmacology and Experimental
Neuroscience, University of Nebraska Medical Center,
Omaha, NE, USA;
399. FOCAS Research Institute, Technological Univer-
sity Dublin, Ireland;
400. Cancer Research Center of Toulouse, National
Institute for Health and Medical Research (INSERM),
Paris, France;
401. Grupo BRAINSHARK, Departamento de Bioloxía
Funcional, Universidade de Santiago de Compostela,
Galiza, Spain;
402. Biology, University of Nebraska at Kearney, NE,
USA;
403. Departament de Genètica i Microbiologia, Univer-
sitat Autònoma de Barcelona, Spain;
404. Chemistry and Industrial Chemistry, University of
Pisa, Italy;
405. Wellcome Trust Centre for Cell-Matrix Research,
University of Manchester, UK;
406. Institute of Human Genetics, CNRS, University of
Montpellier, France;
407. Institute of Organic Chemistry and Biochemistry,
Czech Academy of Sciences, Prague, Czech Republic;
408. Computational Systems Biology Group, National
Center for Biotechnology (CNB-CSIC), Madrid, Spain;
409. Department of Biochemistry and Molecular
Biology, National Cheng Kung University, Tainan,
Taiwan;
410. Ophthalmology, Schepens Eye Research Institute,
Harvard Medical School, Boston, MA, USA;
411. Department of General Surgery, Lanzhou Univer-
sity Second Hospital, Lanzhou, China;
412. School of Life Sciences, University of Technology
Sydney, NSW, Australia;
413. Gynecology, JT Chen Clinic, Tokyo, Japan;
414. Institute of Agriculture, and School of Agriculture
and Environment, The University of Western Australia,
Perth, WA, Australia;
415. Faculty of Geographical Science, Beijing Normal
University, Beijing, China;
416. Electrical Engineering and Computer Science, Uni-
versity of Missouri, Columbia, MO, USA;
417. Department of Public and Occupational Health,
Amsterdam Public Health Research Institute,VUUniversity
Medical Center, Amsterdam, Netherlands;
418. Medical Biochemistry, Semmelweis University,
Budapest, Hungary;
419. Department of Clinical Oncology, Queen Elizabeth
Hospital, Hong Kong, China;
420. Chemistry, University of Pittsburgh, PA, USA;
421. Neurology, G B Pant Institute of Post Graduate
Medical Education and Research, New Delhi, India;
422. Veterinary and Animal Sciences, University of
Copenhagen, Denmark;
423. Section of Endocrinology, Biomedical Department
of Internal and Specialist Medicine (DIBIMIS), University
of Palermo, Italy;
424. Neuroscience, Physiology, and Pharmacology
(NPP), University College London, UK;
425. Microbiology and Cell Science, University of
Florida, Gainesville, FL, USA;
426. School of Health Sciences, University of Salford,
Manchester, UK;
427. Institute of Medical Genetics, Cardiff University,
UK;
428. ICO Cancer Center, Inserm, Angers, France;
429. Microbiology, Faculty of Medicine, University of
Colombo, Sri Lanka;
430. School of Chinese Materia Medica, Beijing Univer-
sity of Chinese Medicine, Beijing, China;
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432. Division of Primary Care, University of Notting-
ham, UK;
433. Pharmacy Systems, Outcomes and Policy, Univer-
sity of Illinois at Chicago, IL, USA;
434. Escola de Ciências Agrárias e Biológicas, Pontifícia
Universidade Católica de Goiás, Brazil;
435. Department of Oncology, China-Japan Friendship
Hospital, Beijing, China;
436. Chemistry, Boston University, MA, USA;
437. Environmental Science, American University,
Washington, DC, USA;
438. Neuroscience, Carleton University, Ottawa, ON,
Canada;
439. Chemistry and Biochemistry, University of Regina,
SK, Canada;
440. Microbiolgy, Universite de Montreal, Montreal,
QC, Canada;
441. Department of Genetics and Genome Biology,
University of Leicester, UK;
442. School of Agriculture and Food Sciences, The Uni-
versity of Queensland, Gatton, QLD, Australia;
443. BIOM, CNRS, France;
444. The Hatter Cardiovascular Institute, University
College London, UK;
445. Science and Engineering, Flinders University, Ade-
laide, SA, Australia;
446. Engineering, University of Warwick, Coventry, UK;
447. Center for Human Genetics, KU Leuven, Belgium;
448. Department of Macromolecular Science, Fudan
University, Shanghai, China;
449. Biology Education, Dokuz Eylul University, Izmir,
Turkey;
450. Department of Biochemistry and Molecular Biol-
ogy, Indiana University School of Medicine, Indianapolis,
IN, USA;
451. Pulmonary Disease,MondoMedico, Borgomanero,
Italy;
452. U.S. Naval Research Laboratory, Center for Bio/
Molecular Science & Engineering, Washington, DC, USA;
453. Department of Nutrition, Institute of Basic Medical
Sciences, University of Oslo, Norway;
454. Department of Mechanics and Engineering Science,
Peking University, Beijing, China;
455. Department of Pharmacy, Pharmaceutical and
Medicinal Chemistry, Saarland University, Saarbrücken,
Germany;
456. Skin Research Institute, National Institute for
Health and Medical Research (INSERM), Paris, France;
457. Research & Development, Shanghai Proton and
Heavy Ion Center, Shanghai, China;
458. Epidemiology, University of Georgia, Athens, GA,
USA;
459. Department of Plastic and Hand Surgery, Medical
Center, University of Freiburg, Germany;
460. Research, Sidra Medicine, Doha, Qatar;
461. Department of Oral, Maxillofacial and Plastic
Surgery, Rostock University Medical Center, Germany;
462. Emergency Medicine, Brigham & Women’s
Hospital / Harvard Medical School, Boston, MA, USA;
463. Forage Science, AgResearch, Palmerston North,
New Zealand;
464.Medicine, University of California Los Angeles, CA,
USA;
465. Virginia G. Piper Center for Personalized Diagnos-
tics, Biodesign Institute, Arizona State University, Tempe,
AZ, USA;
466. Materials and Engineering Research Institute,
Sheffield Hallam University, Sheffield, UK;
467. respiratory medicine, Aneurin Bevan University
Healthboard, Newport, UK;
468. Neurological Surgery, University of California San
Francisco, CA, USA;
469. UWA Dental School, The University of Western
Australia, Perth, WA, Australia;
470. Biological Sciences, Fordham University, Bronx,
NY, USA;
471. Institute of Biotechnology, University of Helsinki,
Finland;
472. College of Life Sciences, Fujian Normal University,
Fujian, China;
473. Department of Frontier Fiber Technology and
Science, University of Fukui, Japan;
474. Clinical & Experimental Sciences, Faculty of
Medicine, University of Southampton, UK;
475. Department of Biomolecular Sciences, University of
Urbino, Italy;
476. Allergology Unit, Ospedale San Luigi, Torino,
Italy;
477. Department of Urology, Muljibhai Patel Urological
Hospital, Gujarat, India;
478. Stratigraphy and Paleontology, University of
Granada, Spain;
479. School of Veterinary Sciences, Massey University,
Auckland, New Zealand;
480. High Performance Computing and Networking
Institute, National Research Council, Naples, Italy;
481. Division of Metabolism and Children’s Research
Center, University Children’s Hospital Zürich, Switzerland;
482. Biochemistry and Molecular Biology, University of
Melbourne, Parkville, VIC, Australia;
483. Leptospirosis Research and Expertise Unit, Institut
Pasteur, Noumea, New Caledonia;
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485. Biology Animal Department, Sciences
Faculty, Cheikh Anta Diop University (UCAD), Dakar,
Senegal;
486. Earle A. Chiles Research Institute, Providence
Portland Medical Center, Portland, OR, USA;
487. Agriculture and Agri-Food Canada, Lacombe
Research and Development Centre, Lacombe, Canada;
488. Performance Management and Evaluation, Alberta
Innovates, Edmonton, AB, Canada;
489. Instituto de Hortofruticultura Subtropical y
Mediterránea ”La Mayora” (IHSM-UMA-CSIC), Uni-
versidad de Málaga-Consejo Superior de Investigaciones
Científicas, Spain;
490. College of Public Health, Medical and Veteri-
nary Sciences, James Cook University, Cairns, QLD,
Australia;
491. Joint Research Centre, European Commission,
Ispra, Italy;
492. University of Montpellier, France;
493. Commonwealth Scientific and Industrial Research
Organisation (CSIRO), Floreat, WA, Australia;
494. Sun Yat-sen Memorial Hospital, Sun Yat-sen
University, Guangzhou, Guangdong, China;




497. Neurobiology of Vocal Communication, University
Tübingen, Germany;
498. UCCS center for the Biofrontiers Institute, Univer-
sity of Colorado at Colorado Springs, CO, USA;
499. Division of Basic Sciences, Fred Hutchinson Cancer
Center, Seattle, WA, USA;
500. Primary Care Unit, Faculty of Medicine, University
of Geneva, Switzerland;
501. Department of Molecular Genetics and Infection
Biology, Universität Greifswald, Germany;
502. Department of Fine Chemistry, East China Univer-
sity of Science and Technology, Shanghai, China;
503. Surgery, The Ohio State University, Columbus, OH,
USA;
504. R&D, Oragenics, Tampa, FL, USA;
505. Environmental Health Institute, National Environ-
ment Agency, Singapore;
506. Institute of Diagnostic Virology, Friedrich Loeffler
Institute, Insel Riems, Greifswald, Germany;
507.Oncology,TheQueen ElizabethHosptal,Woodville,
SA, Australia;
508. Emerging Pests and Pathogens Research Unit,
USDA, NY, USA;
509. Epilepsy Center, Department of Neurosurgery,
Medical Center, University of Freiburg, Germany;
510. Information and Technology Studies, Faculty of
Education, The University of Hong Kong, Hong Kong,
China;
511. Agricultural and Environmental Biology, Graduate
School of Agricultural and life Sciences, The University of
Tokyo, Japan;
512. Department of Medicine, Pittsburgh Heart, Lung,
and Blood Vascular Medicine Institute, University of
Pittsburgh, PA, USA;
513. Directorate of Transplant, Renal and Urology,
Guy’s & St Thomas’ NHS Foundation Trust, London,
UK;
514. Clinic for Heart, Blood Vessel and Rheumatic Dis-
eases, Clinical Center, University of Sarajevo, Sarajevo;
515. School of Mathematics, Statistics and Actuarial
Science, University of Kent, UK;
516. Department of Life Science and Technology, Tokyo
Institute of Technology, Japan;
517. Laser Center Department of Applied Sciences and
Mechatronics, University of Applied Sciences Munich,
Germany;
518. Nanodevices, CIC nanoGUNE, San Sebastian,
Spain;
519. Gynaecology, VU University Medical Center, Ams-
terdam, Netherlands;
520.Division of PopulationMedicine,Cardiff University
Medical School, UK;
521. Department of Medicine, Karolinska Institute,
Solna, Sweden;
522. Center for Information Biology, National Institute
of Genetics, Mishima, Japan;
523. Harry Perkins Institute of Medical Research,
Murdoch University, Perth, WA, Australia;
524. Physical Education & Sport Sciences, University of
Limerick, Ireland;
525. Campus Clinic Gynecology, Ruhr-University
Bochum Universitätsstr, Bochum, Germany;
526. Epidemiology and Biostatistics, School of Public
Health, Southwest Medical University, Sichuan, China;
527. Center for Molecular Diagnostics, Key labora-
tory of Carcinogenesis and Translational Research (Min-
istry of Education/Beijing), Beijing Cancer Hospital, Beijing,
China;
528. Herpetological Department, Chengdu Institute
of Biology, Chinese Academy of Sciences, Chengdu,
China;
529. Key Laboratory of Nano Biological Effects and
Safety, Beijing, China;
530. PK Sciences, Novartis Institutes for Biomedical
Research (NIBR), Basel, Switzerland;
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532. School of Health Studies, The University ofWestern
Ontario, London, ON, Canada;
533. Health Psychology Group, University of Aberdeen,
UK;
534. Anesthesiology, University of Colorado Anschutz
Medical Campus, CO, USA;
535. Critical Care Medicine, UZA (Antwerp University
Hospital), University of Antwerp, Edegem, Belgium;
536. Endocrinology, Aarhus University Hospital,
Denmark;
537. Industrial and Systems Engineering, Centre for
Transport Development, University of Pretoria, South
Africa;
538. Department of Biostatistics and Bioinformatics,
Duke University, NC, USA;
539. Medical, Pharmaceutical and Biomedical Sci-
ences School, Pontifícia Universidade Católica de Goiás,
Brazil;
540. Division of Cardiovascular Medicine, Department
of Clinical Sciences, Danderyd Hospital, Karolinska Insti-
tutet, Stockholm, Sweden;
541. Clinical, Educational and Health Psychology, Uni-
versity College London, UK;
542. Development and Differentiation Research Center,
Korea Research Institute of Bioscience and Biotechnology
(KRIBB);
543. Laboratoire de la Barrière Hémato-encéphalique,
Université d’Artois, Arras, France;
544. Quantitative Biology, Discovery Sciences,
IMED Biotech Unit, AstraZeneca, Cambridge,
UK;
545. Environmental Molecular Sciences Laboratory,
Pacific Northwest National Laboratory, Richland, WA,
USA;
546. Statistical Physics Group, Applied Maths Research
Centre, Coventry University, UK;
547. Invista Performance Technologies, TheWilton Cen-
tre, Cleveland, UK;
548. Genome Research, Thünen Institute of Forest
Genetics, Großhansdorf, Germany;
549. Natural Sciences, Lebanese American University,
Byblos, Lebanon;
550. Evidence and Value Generation, Takeda, Osaka,
Japan;
551. Stem Cell and Regenerative Medicine, King Abdul-
lah International Medical Research Center, Riyadh, Saudi
Arabia;
552. Industries - Pulp and Paper, University of Bahri,
Khartoum, Sudan;
553.Mater Research Institute-The University of Queens-
land, Mater Medical Research Institute, Brisbane, QLD,
Australia;
554.NREL,Colorado State University, Fort Collins, CO,
USA;
555.Ob/Gyn Department, Rzeszow University Hospital,
Rzeszow, Poland;
556. Faculty of Biological Sciences, University of Leeds,
UK;
557. Endocrine Unit, Massachusetts General Hospital,
Boston, MA, USA;
558. Neuroscience, University of Oldenburg, Germany;
559. Microbiome Research Centre, St George & Suther-
land Clinical School, UNSW Sydney, NSW,z Australia;
560. Departments of Biochemistry & Molecular Phar-
macology, New York University School of Medicine, NY,
USA;
561. Medicine/Infectious Diseases, University of Missis-
sippi Medical Center, Jackson, MS, USA;
562. Faculty of Social Sciences / Psychology, Tampere
University, Finland;
563. Department of Biological Sciences, University of
Cyprus, Nicosia, Cyprus;
564. Institute of Medical Microbiology and Infection
Control, Goethe University, Frankfurt, Germany;
565. Institute for Radiology, Charité Medical University
of Berlin, Germany;
566. Internal Medicine I, University Hospital Cologne,
University of Cologne, Germany;
567. Section of Periodontics, School of Dentistry, Uni-
versity of California Los Angeles, CA, USA;
568. Department of Clinical Biochemistry, Aalborg Uni-
versity Hospital, Denmark;
569. Pharmacy Practice, Manipal Academy of Higher
Education, India;
570. Department of Radiology, Institute of Medical Sci-
ence, The University of Tokyo, Japan;
571. Family Medicine, Faculty of Medicine, Çukurova
University, Adana, Turkey;
572. Department of Humanities and Social Medicine,
College of Medicine, The Catholic University of
Korea;
573. Food Technology, Safety and Health, Ghent Univer-
sity, Belgium;
574. School of Biological, Earth and Environmental
Sciences (BEES), UNSW Sydney, NSW, Australia;
575. Research Unit, St. Vincent Shoulder & Sports Clinic
Vienna, Austria;
576. Biomedical Engineering, Cornell University, Ithaca,
NY, USA;
577. Research Group Bioinformatics And Information
Technology, Leibniz Institute of Plant Genetics and Crop
Plant Research (IPK) Gatersleben, Germany;
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579. BiomedicalManufacturing,CSIROManufacturing,
Melbourne, VIC, Australia;
580. Biological Sciences, DePaul University, Chicago, IL,
USA;
581. Department of Animal Science and Technology,
Konkuk University, Seoul, Korea;
582.Graduate Institute ofMedicalMechatronics,Chang
Gung University, Taoyuan, Taiwan;
583. Psychiatry, College of Medicine, Korea University,
Seoul, Korea;
584. Chemistry, Princeton University, NJ, USA;
585. Henan Key Laboratory of Chinese Medicine
for Respiratory Disease, Henan University of Chinese
Medicine, Henan, China;
586. Department of Psychiatry and Psychotherapy,
University Medical Center Mainz, Germany;
587. School of Science, Monash University Malaysia,
Selangor, Malaysia;
588. Physiology and Biophysics, University of Missis-
sippi Medical Center, Jackson, MS, USA;
589. Department of Transplantation Medicine, Univer-
sity of Oslo, Norway;
590. Triticeae Research Institute, Sichuan Agricultural
University, Sichuan, China;
591. Gastroenterology, Guangzhou University of
Chinese Medicine, Guangzhou, China;
592. School of Biological Science & Medical Engineer-
ing, Southeast University, Jiangsu, China;
593. Biology, Mount Allison University, Sackville, NB,
Canada;
594. Biology, Ithaca College, Ithaca, NY, USA;
595. Department of medical Sciences and Public Health,
University of Cagliari, Monserrato, Italy;
596. Chromosome Biology, University of Vienna,
Austria;
597. Nephrology, University of Zürich, Switzerland;
598. Institute of Nutritional Sciences, Friedrich Schiller
University, Jena, Germany;
590. Graduate School of Biomedical Engineering,
UNSW Sydney, NSW, Australia;
600. Biochemistry and Molecular Biology, Tulane
University School of Medicine, New Orleans, LA, USA;
601. National Institute of Neurological Disorders and
Stroke, National Institutes of Health, Bethesda, MD, USA;
602. NCBI, NLM, National Institutes of Health,
Bethesda, MD, USA;
603. L’Oréal Research and Innovation,Aulnay sous Bois,
France;
604. Department of Psychology, Lund University,
Malmö, Sweden;
605. Institut de Recherche Expérimentale et Clinique,
Université Catholique de Louvain, Brussels, Belgium;
606. Neuroscience Institute, Georgia State University,
Atlanta, GA, USA;
607. Surgery, Ophthalmology, University of Melbourne,
Parkville, VIC, Australia;
608. Centre for Ophthalmology and Visual Science, The
University of Western Australia, Perth, WA, Australia;
609. Medical Physics, Faculty of Medicine, Iran Univer-
sity of Medical Sciences, Tehran, Iran;
610. Cellular Neurobiology, Salk Institute, La Jolla, CA,
USA;
611. Fibrosis Research Group, Imperial College London,
UK;
612. Genitourinary Medical Oncology, University of
Texas MD Andersson Cancer Center, Houston, TX, USA;
613. GIGA-Neurosciences, University of Liege,
Belgium;
614. Urology, School of Medicine, University of Crete,
Greece;
615. Department of Clinical Pharmacology, Flinders
Medical Centre, Flinders University, Adelaide, SA,
Australia;
616. Bioinformatics, Max Planck Institute of Immuno-
biology and Epigenetics, Breisgau, Germany;
617. School of Psychology, Cardiff University, UK;
618. Chemical Engineering, Imperial College London,
UK;
619. Clinical Sciences, Skane University Hospital, Lund
University, Malmö, Sweden;
620. Department of Molecular and Clinical Medicine,
Sahlgrenska Academy, Institution of Clinical Science;
621. School of Pharmacy and Biomedical Sciences, Uni-
versity of Central Lancashire, Preston, UK;
622. Psychiatry & Clinical Psychology, Hospital Univer-
sitario Doctor Peset, Valencia, Spain;
623. Genome Dynamics and Function, Centro de Biolo-
gia Molecular Severo Ochoa, Madrid, Spain;
624. Department of Intensive Care, Unviversity Hospital
of Lille, France;
625. Surgery, Kansai Medical University, Osaka, Japan;
626. Laboratory of Genomics and Biotechnology
of Fruit, École Nationale Supérieure Agronomique de
Toulouse, Institut National Polytechnique de Toulouse,
Université de Toulouse, France;
627. Institute for Psychology,UiT - The Arctic University
of Norway, Tromstø, Norway;
628. Centre for Public Health, Queen’s University
Belfast, UK;
629. Centre for Primary Care and Health Services
Research, University of Manchester, UK;
630. Menzies Health Institute, Griffith University, Gold
Coast, QLD, Australia;
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632. Department of Experimental Medicine, Universitat
de Lleida, Spain;
633. Biomolecular Screening Branch, Division National
Toxicology Program, National Institute of Environmental
Health Sciences, NC, USA;
634. Immunology and Microbial Disease, Albany Med-
ical College, NY, USA;
635. Queensland Brain Institute, The University of
Queensland, Brisbane, QLD, Australia;
636. School of Biosciences, University of Kent,
UK;
637. LNC, UMR 1231, Inserm, Université Bourgogne
Franche-Comté, Cedex, France;
638. Department of Biotechnology, College of Life
Sciences, Ritsumeikan University, Shiga, Japan;
639. Biological Sciences, Kent State University, OH,
USA;
640. Department of Safety Research on Blood and Bio-
logical Product, National Institute of Infectious Diseases,
Tokyo, Japan;
641. Laboratory of Microbiology of Extreme Environ-
ments, European Institute for Marine Studies, Plouzané,
France;
642. Department of Pharmacology, Roy J. and Lucille A.
Carver College of Medicine, University of Iowa, Iowa City,
IA, USA;
643. Biological Sciences, National University of
Singapore;
644.Laboratoire GBA,EA4627,Conservatoire National
des Arts et Métiers, Paris, France;
645. Department of Human Genetics, University of
Michigan, MI, USA;
646. Belozersky Institute of Physico-Chemical Biology,
Lomonosov Moscow State University, Russia;
647. Department of Molecular Biology, The Jikei Uni-
versity School of Medicine, Tokyo, Japan;
648. Genomics & Computational Biology, University of
South Wales, Treforest, UK;
649. Obstetrics and Gynecology, Duke University Med-
ical Center, Durham, NC, USA;
650. Climate Change Cluster, University of Technology
Sydney, NSW, Australia;
651. Department of Radiology, Nagoya University
Graduate School of Medicine, Aichi Prefecture,
Japan;
652. School of Science and Health, Western Sydney
University, NSW, Australia;
653. Department of Speech and Language Therapy, TEI
of Epirus, Ioannina, Greece;
654. Orthopaedic Surgery, Indiana University-Purdue
University, IN, USA;
655. Veterinary Pathology, Oniris, Nantes, France;
656. Pathobiology and Population Sciences, Royal Vet-
erinary College, Hertfordshire, UK;
657. Lab of Pharmaceutical Biotechnology, Ghent Uni-
versity, Belgium;
658. Terrestrial Ecology, Norwegian Institute for Nature
Research, Trondheim, Norway;
659. Molecular and Cell Biology, University of Califor-
nia Merced, CA, USA;
660. Centre for Transport Research, School of Engi-
neering, Trinity College Dublin, The University of Dublin,
Ireland;
661. Nephrology, Institution of Clinical Sciences, Lund
University, Malmö, Sweden;
662. Mechanical Engineering, University of Birming-
ham, UK;
663. OB/GYN, Institution of Clinical Sciences, Lund
University, Lund, Sweden;
664. Nephrology and Hypertension, Fundación Jiménez
Diaz Hospital, Madrid, Spain;
665. School of Chemistry, Physics and Mechanical Engi-




667. Department of Experimental Neurodegeneration,
University Medical Center Göttingen, Germany;
668. Physical Medicine and Rehabilitation, Harvard
Medical School, Spaulding Rehabilitation Hospital, Boston,
MA, USA;
669. Scientific Operations, Quadram Institute Bio-
science, Norwich, UK;
670. Regensburg Medical Image Computing (ReMIC),
Ostbayerische Technische Hochschule Regensburg (OTH
Regensburg), Germany;
671. Faculty of Arts and Education, Deakin University,
Melbourne, VIC, Australia;
672. Warwick Medical School, University of Warwick,
Coventry, UK;
673. Biochemistry & Molecular Biology, National Insti-
tute for Health and Medical Research (INSERM), Paris,
France;
674. Tax Institute, Université de Liège, Belgium;
675. School of Molecular and Cellular Biology, Univer-
sity of Leeds, UK;
676. UOC Genetica Medica, IRCCS Istituto Giannina
Gaslini, Genova, Italy;
677. Science, Research Diets, Inc., New Brunswick, NJ,
USA;
678. Department of Physics and Geology, University of
Perugia, Italy;
679. Cellular Immunology, Walter Reed National Mili-
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680. Microbiology, Immunology and Parasitology
Departament, Biological Science Center, Federal University
of Santa Catarina, Brazil;
681.Centre for Liver andDigestive Disorders, The Royal
Infirmary, University of Edinburgh, UK;
682. Critical Care Proprietary Products Division, Orion
Pharma, Espoo, Finland;
683. Department of Civil and Environmental Engineer-
ing, Massachusetts Institute of Technology, Cambridge,
MA, USA;
684. Department of Veterinary Sciences, University of
Turin, Italy;
685. Dept. Psychological, Health and Territorial Sci-
ences, University of Chieti, Italy;
686.OB-GYN,NewYorkUniversity School ofMedicine,
New York, NY, USA;
687. Institute of Cardiovascular and Medical Sciences,
University of Glasgow, UK;
688. Department of Biology, University of Turku,
Finland;
689. Bioanalytics, Technische Universitaet Berlin,
Germany;
690. University of Goettingen, Third Institute of Physics
- Biophysics, Germany;
691. Translational Research to Advance Therapeutics
and Innovation in Oncology (TRACTION), Institute for
Applied Cancer Science, The University of Texas MD
Anderson Cancer Center, Houston, TX, USA;
692. Life Sciences, University of Liège, Belgium;
693. Department of Toxicology, Faculty of Medical Sci-
ences, Tarbiat Modares University, Tehran, Iran;
694. Agricultural Research Service, USDA, Stoneville,
MS, USA;
695.RCI Regensburg Center of Interventional Immunol-
ogy, University of Regensburg, Germany;
696. School of Psychology, University of Nottingham,
UK;
697. Laboratory of Pathology, National Institutes of
Health, Bethesda, MD, USA;
698. Electrical Engineering, Universidad Carlos III de
Madrid, Spain;
691. Chemical Biology, Instituto deMedicinaMolecular,
Lisbon, Portugal;
700. CIET, University of Costa Rica;
701. Faculty of Health Sciences, University of Stavanger,
Norway;
702. Urology, Erasmus University Medical Center,
Rotterdam, Netherlands;
703. School of Biological Sciences, University of
Edinburgh, UK;
704. Institute for Bioinformatics and Systems Biology
(IBIS), Helmholtz Zentrum München-German Research
Center for Environmental Health (GmbH), Ingolstädter
Landstraße 1, D-85764 Neuherberg, Germany;
705. Huygens-Kamerlingh Onnes Laboratory, Leiden
University, Netherlands;
706. Nutritional Sciences, University of Vienna,
Austria;
707. Medicine, Kolling Institute of Medical Research, St
Leonards, NSW, Australia;
708. Biological Chemistry, Johns Hopkins School of
Medicine, Baltimore, MD, USA;
709. Medicine / Nutrition and Microbiome Laboratory,
Universite de Montreal, Montreal, QC, Canada;
710. Cell and Gene Therapy, GlaxoSmithKline,
Stevenage, UK;
711. Life Sciences, University of Trieste, Italy;
712. Department of Radiology, RWTH Aachen Univer-
sity, Aachen, Germany;
713. Department of Medical Oncology, West German
Cancer Center, University Hospital Essen, University of
Duisburg-Essen, Germany;
714. Obstetrics & Gynecology, Medical University of
Vienna, Austria;
715. Social and Behavioral Health Sciences Division,
FHI 360, Washington, DC, USA;
716. VIB Switch Laboratory, VIB-KU Leuven,
Belgium;
717. Faculty of Technology, Bielefeld University,
Germany;
718. Department of Gastrointestinal Surgery, Depart-
ment of Clinical Nutrition, Beijing Shijitan Hospital, Capi-
tal Medical University, Beijing, China;
719. Department of Agricultural Chemistry, Meiji Uni-
versity, Kawasakishi, Japan;
720. Microbiology, Yonsei University College of
Medicine, Seoul, Korea;
721. Johnson & Johnson EAME, Maidenhead, UK;
722. Pediatrics, Penn State College of Medicine, PA,
USA;
723. Department of Social Medicine, University of
North Carolina at Chapel Hill, NC, USA;
724. ARC CoE Plant Energy Biology, The University of
Western Australia, Perth, WA, Australia;
725.Division ofHumanNutrition andHealth,Wagenin-
gen University, Wageningen, Netherlands;
726. Department of Neuroimaging, King’s College
London, UK;
727. Biochemistry & Molecular Biology, University of
Murcia, Spain;
728. Department of Biological Sciences, Old Dominion
University, Norfolk, VA, USA;
729. Biochemistry and Molecular Biology, Monash Uni-
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730. Institute of Genetics and Developmental Biology,
Chinese Academy of Sciences, Beijing, China;
731. Pharmacology & Chemical Biology, University of
Pittsburgh, PA, USA;
732. Center for Integrative Genomics, University of
Lausanne, Switzerland;
733. School of Pharmacy, The University of Queensland,
Brisbane, QLD, Australia;
734. Genebank, Leibniz Institute of Plant Genetics and
Crop Plant Research (IPK) Gatersleben, Germany;
735. Research and Development, Piramal Imaging,
Berlin, Germany;
736. Civil Engineering, University of Leeds, UK;
737.Chemistry and Biochemistry,University ofMissouri
St. Louis, MO, USA;
738. Coastal andMarine Geology Program, US Geologi-
cal Survey,USGS Pacific Coastal andMarine Science Center,
Santa Cruz, CA, USA;
739. Ajinomoto-Genetika Research Institute, Moscow,
Russia;
740. Department of Plant Biotechnology, Faculty of
Biochemistry, Biophysics and Biotechnology, Jagiellonian
University, Kraków, Poland;
741. Engineering Science and Materials, University of
Puerto Rico, Mayagüez, PR, USA;
742. Department of Chemistry and Biochemistry, Uni-
versity of Regina, SK, Canada;
743.Center forNanoscaleMateriaals,ArgonneNational
Laboratory, IL, USA;
744. Sunshine Coast Mind & Neuroscience - Thomp-
son Institute, University of the Sunshine Coast, QLD,
Australia;
745. Department of Gastroenterology and Hepa-
tology, The Chinese PLA General Hospital, Beijing,
China;
746. Griffith Centre for Social and Cultural Research,
Griffith University, Gold Coast, QLD, Australia;
747.Department ofMolecular Oncology, Inst Dev Aging
Cancer, Tohoku University, Sendai, Japan;
748. Computer Science, Indiana University, Blooming-
ton, IN, USA;
749. Department of Pulmonary Medicine, Fukushima
Medical University School of Medicine, Fukushima,
Japan;
750. Biology, MEDIVIR AB, Huddinge, Sweden;
751. Neuroimmunology, Western Sydney University,
NSW, Australia;
752. Nutrition and Food Technology, The University of
Jordan;
753. Institute of Biodiversity, Federal Research Center
for Rura Areas, Forestry and Fisheries, Thünen Institute of
Forest Genetics, Großhansdorf, Germany;
754. Institute of Cell Biology and the Centre for Integra-
tive Physiology, University of Edinburgh, UK;
755. Structural Genomics Consortium, University of
Toronto, ON, Canada;
756. Graduate Education and Research, Canadian
Memorial Chiropractic College, Toronto, ON, Canada;
757. R&D, Agilent Technologies, Leuven, Belgium;
758. School of Nursing, The University of British
Columbia, Vancouver, BC, Canada;
759. Stroke and Ageing Research, Department of
Medicine, School of Clinical Sciences at Monash Health,
Monash Univerity, Melbourne, VIC, Australia;
760. Biology, Transfer, Innovations, French National
Cancer Institute, Boulogne-Billancourt, France;
761. NanoBioSciences, Physical Chemistry, Ludwig
Maximilians-Universität München, Germany;
762.Medicinal Chemistry, School of Pharmacy, Bandung
Institute of Technology, Indonesia;
763. Life Sciences Research Unit, University of
Luxembourg;
764. Department of Gastroenterology, Skane University
Hospital, Lund University, Malmö, Sweden;
765. Translational Genetics, Millennium Health, San
Diego, CA, USA;
766. Clinical Research and Evidence-Based Medicine
Unit, Second Medical Department, Aristotle University
Thessaloniki, Greece;
767. Department of Psychology, The Jan Kochanowski
University in Kielce, Piotrków Trybunalski Branch, Poland;
768. Engineering Physics, McMaster University,
Hamilton, ON, Canada;
769. Department of Agriculture, Food and Environ-
mental Sciences, Marche Polytechnic University, Ancona,
Italy;
770. Microbiology, Faculty of Medicine, Kuwait
University;
771. Department of Breast Surgery, Fujita Health Uni-
versity, Aich, Japan;
772. Spinal Injuries Centre, North West Regional Spinal
Injuries Centre, Merseyside, UK;
773. Competence Centre in Methodology and Statistics,
Luxembourg Institute of Health;
774. Metabolic Health, Nestle Institute of Health Sci-
ences SA, Écublens, Vaud, Switzerland;
775. VIB Center for Inflammation Research, Ghent,
Belgium and Department of Biomedical Molecular Biology,
Ghent University, Ghent, Belgium;
776. Currículo, formaÇão de professores e tecnolo-
gia, Instituto de EducaÇão da Universidade de Lisboa,
Portugal;
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778. School of BioSciences, University of Melbourne,
Parkville, VIC, Australia;
779. Computer and Information Sciences, Northumbria
University, Newcastle upon Tyne, UK;
780. Endocrinology, University of Valencia, Spain;
781. INRS-Institut Armand-Frappier, INRS, Laval, QC,
Canada;
782. School of Nutrition, INAF, Université Laval,
Québec City, QC, Canada;
783. Department of Biology, University of Konstanz,
Konstanz, Germany;
784. Université Côte d’Azur, LAMHESS, France;
785. Systems Ecology, Scion, Christchurch, New
Zealand;
786. Epidemiology and Biostatistics, CUNY Grad-
uate School of Public Health and Health Policy, NY,
USA;
787. School of Dentistry, The University of Queensland,
Brisbane, QLD, Australia;
788. The Renal and Metabolic Division, The George
Institute for Global Health, Sydney, NSW, Australia;
789. College of Chemistry & Molecular Sciences,
Wuhan University, Hubei, China;
790. School of Environment and Science, Griffith Uni-
versity, Gold Coast, QLD, Australia;
791. Radiation Oncology, University of Minnesota,
Minneapolis, MN, USA;
792. Faculty of Medicine, Goethe University, Frankfurt,
Germany;
793. Department and Graduate School of Safety and
Environment Engineering, National Yunlin University of
Science & Technology, Taiwan;
794. School of Sport, Exercise and Nutrition, Massey
University, Auckland, New Zealand;
795. Wildlife Ecology and Conservation, University of
Florida, Gainesville, FL, USA;
796. Department of Psychology, Bournemouth Univer-
sity, Poole, UK;
797. Project Group P2, Robert Koch Institute, Berlin,
Germany;
798.MRC Institute of Genetics andMolecularMedicine,
University of Edinburgh, UK;
799. Biozentrum, University of Basel, Switzerland;
800. School of Medicine, University of Wollongong,
Wollongong, NSW, Australia;
801. Institute of HumanGenetics,University of Cologne,
Germany;
802. Rural Economics Branch, Economic Reserach Ser-
vice, Washington, DC, USA;
803. Institut de Neurosciences Cognitives et Inté-
gratives d’Aquitaine, CNRS, Uiversity of Bordeaux,
France;
804. Department of Chemical & Environmental Engi-
neering and Materials Science & Engineering Program,
University of California Riverside, CA, USA;
805. Department of Medicine,MackayMedical College,
New Taipei City, Taiwan;
806. Division of Animal Welfare, University of Bern,
Switzerland;
807. Department of Physiology and Pharmacology,
Oregon Health & Science University, Portland, OR,
USA;
808. Institute of Interdisciplinary Medical Science,
Shanghai University of Traditional Chinese Medicine,
Shanghai, China;
809. Biology, McMaster University, Hamilton, ON,
Canada;
810. Department of Cell Biology, Microbiology and
Molecular Biology, University of South Florida, Tampa, FL,
USA;
811. Medical Oncology, Hacettepe University Institute
of Cancer, Ankara, Turkey;
812. Department of Electronic Engineering, City Univer-
sity of Hong Kong, Hong Kong, China;
813. Department of Entomology, National Taiwan Uni-
versity, Taipei, Taiwan;
814. Ecological Security, Institute of Environment and
Sustainable Development in Agriculture, Chinese Academy
of Agricultural Sciences, Beijing, China;
815. Chemistry and Biochemistry, Institute of Molec-
ular Biophysics, Florida State University, Tallahasse, FL,
USA;
816. Lab of Computational Chemistry and Drug
Design, State Key Laboratory of Chemical Oncogenomics,
Peking University Shenzhen Graduate School, Shenzhen,
China;
817. Drug Research Program, Division of Pharmaceuti-
cal Chemistry and Technology, Faculty of Pharmacy, Uni-
versity of Helsinki, Finland;
818. Microbial Biotechnology, Tohoku University,
Sendai, Japan;
819. Department of Pharmacology, School of Basical
Medical Sciences, Tianjin Medical University, Tianjin,
China;
820. Biostatistics and Computational Biology, Dana Far-
ber Cancer Institute, Boston, MA, USA;
821. Institute of Molecular and Genomic Medicine,
National Health Research Institutes, Taiwan;
822. Physiology Anatomy and Genetics, University of
Oxford, UK;
823. Physics, George Washington University, Washing-
ton, DC, USA;
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825. Department of Laboratory Medicine and Pathobi-
ology, Toronto General Hospital Research Institute, ON,
Canada;
826. Biological Sciences, The University of Texas at
Dallas, Richardson, TX, USA;
827. Department of Chemistry, New York University,
NY, USA;
828. School of Mathematics and Statistics, Shandong
University, Shandong, China;
829. Hefei National Laboratory for Physical Science
at Microscale and School of Life Sciences, University of
Science and Technology of China, Anhui, China;
830.Medicinal Chemistry andMolecular Pharmacology,
Purdue University, West Lafayette, IN, USA;
831. Advanced Therapies, National Institute for Biolog-
ical Standards and Control (NIBSC), Herts, UK;
832. Department of Pulmonary &
Critical Care Medicine, Ruijin Hospital Affiliated to
Shanghai Jiao Tong University, Shanghai, China;
833. Dermatology and Allergy, Charité
Medical University of Berlin, Germany;
834. Hematology, University Hospital of Saint-Etienne,
France;
835. Institute of Biotechnology, Inland Norway Univer-
sity of Applied Sciences;
836. Pediatrics, The University of Jordan;
837. Molecular mycology unit, Institut Pasteur, Paris,
France;
838. Medical Research Council Centre for Neuropsy-
chiatric Genetics and Genomics, Institute of Psychological
Medicine and Clinical Neurosciences, School of Medicine,
Cardiff University, UK;
839. Social Work, Zurich University of Applied Sciences,
Switzerland;
840. School of Life Sciences, Jawaharlal Nehru Univer-
sity, New Delhi, India;
841. LE2I, University of Burgundy - Franche-Comté,
Dijon, France;
842. Life Sciences, University of Roehampton, London,
England;
843. General and HPB Surgery, Ghent University Hospi-
tal, Belgium;
844. Insect-Fungus Symbiosis lab,University ofWuerzburg,
Germany;
845. Behavioural Science Institute, Radboud University,
Nijmegen, Netherlands;
846. Application center HOFZET, Fraunhofer WKI,
Hannover, Germany;
847. Structural and Molecular Biology, University Col-
lege London, UK;
848. Developmental Psychology, University of Amster-
dam, Netherlands;
849. CNAP, SMI, Health Science and Technology,
Aalborg University, Denmark;
850. Center for Health Equity Research and Promotion,
VA Pittsburgh Healthcare System, Pittsburgh, PA, USA;
851. Neurosurgery, Cedars Sinai Medical Center, Los
Angeles, CA, USA;
852. School of Data and Computer Science, Sun Yat-sen
University, Guangzhou, Guangdong, China;
853. Shandong Provincial Key Laboratory of Biophysics,
Dezhou University, Shandong, China;
854. UMR Espace-DEv, Institut de Recherche pour le
Développement, Maison de la Télédétection, Montpellier,
France;
855. School of Life Sciences, Xiamen University, Fujian,
China;
856. Department of Medical Imaging, National Clinical
Research Center of Kidney Diseases, Jinling Hospi-
tal, Nanjing University School of Medicine, Nanjing,
China;
857. School of Social Policy, Sociology and Social
Research, University of Kent, UK;
858. Infectious Diseases and Tropical Medicine, Federal
University of Minas Gerais, Brazil;
859. Life and Health Sciences Research Institute (ICVS)
- School of Medicine, University of Minho, Braga, Portugal;
860. Biochimie et Médecine Moléculaire, Universite de
Montreal, Montreal, QC, Canada;
861. Epidemiology, Johns Hopkins Bloomberg School of
Public Health, Baltimore, MD, USA;
862. Metabolic and Genetic Regulation of Ageing, Max
Planck Institute for Biology of Ageing, Cologne, Germany;
863. Health Sciences, University of Swaziland;
864. Institute for Future Environments,Queensland Uni-
versity of Technology, Brisbane, QLD, Australia;
865. Département de Biologie Médicale, Centre Scien-
tifique de Monaco;
866. Urology, HELIOS Hospital, Bad Saarow, Germany;
867. Institute of Microbiology, Technische Universität
Braunschweig, Germany;
868. Fetal i+D Fetal Medicine Research Center,
IDIBAPS BCNatal — Barcelona Center for Maternal Fetal
and Neonatal Medicine, Hospital Clínic and Hospital Sant
Joan de Déu, Universitat de Barcelona, Spain;
869. Institute of Bacterial Infections and Zoonoses,
Friedrich Loeffler Institut, Jena, Germany;
870. Neurology, Charité
Medical University of Berlin, Germany;
871. Molecular Therapeutics for Cancer in Ireland,
National Institute for Cellular Biotechnology, Dublin City
University, Ireland;
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873. Institute for Sex Research and Forensic Psychiatry,
University Medical Center Hamburg Eppendorf, Germany;
874. School of Mathematical Sciences and LPMC,
Nankai University, Tianjin, China;
875. Oncology, University of Oxford, UK;
876. Classics, Royal Holloway, Egham, UK;
877. Clinical Sciences, Cornell University, Ithaca, NY,
USA;
878. Pharmaceutical Chemistry, University of KwaZulu-
Natal, Westville Campus, Durban, South Africa;
879. Medicine, Royal College of Surgeons in Ireland,
Dublin, Ireland;
880. Department of Immunology, University of Oslo,
Norway;
881.Marine Nitrogen Cycling Lab, Bermuda Institute of
Ocean Sciences, St. George’s, Bermuda;
882. Institute of Liberal Arts and Sciences, Kanazawa
University, Japan;
883. World Health Organization Regional Office for
Africa, Brazzaville, Congo;
884. Infection Control Department, University Hospital
of BesanÇon, France;
885. Clinical Development, Galapagos NV, Mechelen,
Belgium;
886. Integrated Marine Observing System, University of
Tasmania, Hobart, TAS, Australia;
887. Department of Systematics, Biodiversity and Evo-
lution of Plants, Albrecht-von-Haller Institute for Plant
Sciences, Georg August University of Göttingen, Germany;
888 Department of Psychiatry, University of Occupa-
tional and Environmental Health, Fukuoka, Japan;




891. Department of Cardiovascular Surgery, Maastricht
University, Maastricht, Netherlands;
892. Institute for Clinical Biochemistry and Pathobio-
chemistry, German Diabetes Center, Düsseldorf, Germany;
893. Department of Radiology, Juntendo University
Graduate School of Medicine, Tokyo, Japan;
894. School of Information Technology, Deakin Univer-
sity, Melbourne, VIC, Australia;
895.Department of Interface Chemistry and Surface Sci-
ence, Max-Planck-Institut fur Eusenforschung, Dusseldorf,
Germany;
896. Department of Psychology, Edge Hill University,
Ormskirk, UK;
897. Psychiatry, Aga Khan University, Karachi,
Pakistan;
898. Korean Bioinformation Center, Korea Research
Institute of Bioscience and Biotechnology (KRIBB);
899. Health Economics and Outcomes Research, Cardi-
nal Health Specialty Solutions, Dallas, TX, USA;
900. Division of Clinical Pharmacology, Klinikum der
Universität München, Germany;
901. Neurological Surgery, University of Pittsburgh, PA,
USA;
902. Department of Child and Adolescent Psychiatry,
Psychosomatics, and Psychotherapy, RWTH Aachen Uni-
versity, Aachen, Germany;
903. Institute of Molecular and Cellular Biology, Univer-
sity of Copenhagen, Denmark;
904. Structural Biology, St. Jude Children’s Research
Hospital, Memphis, TN, USA;
905. Colorectal Surgery, Royal Shrewsbury Hospital,
UK;
906. Faculty of Medicine & Health Sciences, University
of Nottingham, UK;
907. Department of Physiology and Pharmacology,
Karolinska Institutet, Solna, Sweden;
908. State Key Lab of Electroanalytical Chemistry,
Changchun Institute of Applied Chemistry, Chinese
Academy of Sciences, Jilin, China;
909. Pediatrics, The University of British Columbia,
Vancouver, BC, Canada;
910. Cotton Germplasm Resources, Research Base in
Anyang Institute of Technology, State Key Laboratory
of Cotton Biology/Institute of Cotton Research, Chinese
Academy of Agricultural Sciences, Beijing, China;
911. Anaesthesia and Intensive care, The Chinese Uni-
versity of Hong Kong, Hong Kong, China;
912. ICMS, University of Macau, Guangdong, China;
913. School of Renewable Energy, North China Electric
Power University, Beijing, China;
914. Department of Internal Medicine, Justus-Liegbig
University, Giessen, Germany;
915. Bioscience, Aarhus University, Denmark;
916. The Irish Longitudinal Study on Ageing (TILDA),
Trinity College Dublin, The University of Dublin,
Ireland;
917.Hematology,UniversityMedical Center Groningen,
University of Groningen, Netherlands;
918. Child Neurology, VU University Medical Center,
Amsterdam, Netherlands;
919. EuropeanMolecular Biology Laboratory, European
Bioinformatics Institute (EMBL-EBI), Cambridge, UK;
920. HGF MPG Joint Research Group for Deep-Sea
Ecology and Technology, Max Planck Institute for Marine
Microbiology, Bremen, Germany;
921. Center for Adaptive Rationality, Max Planck Insti-
tute for Human Development, Berlin, Germany;
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923. School of Nursing&Midwifery,Griffith University,
Gold Coast, QLD, Australia;
924. The Roy J. Carver Department of Biochemsitry,
Biophysics and Molecular Biology, Iowa State University,
Ames, IA, USA;
925. Engineering Thermodynamics, Process & Energy
Department, Faculty of Mechanical, Maritime and Materi-
als Engineering, Delft University of Technology, Leeghwa-
terstraat 39, 2628CB, Delft, The Netherlands;
926. Cytotechnology Education, College of Allied
Health Professions, University of NebraskaMedical Center,
Omaha, Nebraska, USA;
927. Department of Cardiovascular Medicine, Shinko
Memorial Hospital, Kobe, Japan;
928. Materials, Imperial College London, UK;
929. Department of Surgery, Technical University of
Munich, München, Germany;
930. Laboratory of Quality and Safety Risk Assessment
for Fruit (Xingcheng), Ministry of Agriculture, Research
Institute of Pomology, Chinese Academy of Agricultural
Sciences, Liaoning, China;
931. Communication Sciences and Disorders, James
Madison University, Harrisonburg, VA, USA;
932. Institute for Orthopaedic Research and Biomechan-
ics, University Hospital Ulm, Germany;
933. School of Health and Social Care, University of
Essex, UK;
934. Research Services, Alpha-Altis, Nottingham,
UK;
935. Medical Oncology, Erasmus University Medical
Center, Rotterdam, Netherlands;
936. Department of Industrial Chemistry, Federal Uni-
versity Oye, Ekiti, Nigeria;
937. Cell Biology, Duke University Medical Center,
Durham, NC, USA;
938. Nuffield Department of Clinical Neurosciences,
University of Oxford, UK;
939. Cancer Research UK Manchester Institute, Univer-
sity of Manchester, UK;
940. Children’s Hospital, Helsinki University Hospital,
Finland;
941. Department of Biology, CESAM - Centre for
Environmental and Marine Studies, University of Aveiro,
Portugal;
942. Psychology, University of Botswana, Gaborone,
Botswana;
943. Nursing School, Federal University of Bahia,
Canela, Salvador-Bahia;
944. Biological and Experimental Psychology, Queen
Mary University of London, UK;
945. Medicinal Chemistry Department, National Uni-
versity of Pharmacy, Kharkiv, Ukraine;
946. Department of Education and Psychology, Univer-
sity of Bolton, UK;
947. Department of Chemistry and Physics, La Trobe
University, Melbourne, VIC, Australia;
948. Department of Gastroenterology, General Hospital
of Northern Theater Command, Liaoning, China;
949. Department of Nephrology, Doctors Hospital
Athens, Greece;
950. Pediatrics III, University Hospital Essen, Germany;
951. Infectious Disease Epidemiology, Imperial College
London, UK;
952. Department of Psychiatry, Sorbonne Universite,
Paris France;
953. Education, UNSW Sydney, NSW, Australia;
954. Department of Psychiatry & Behavioral Sciences,
Stanford University, Palo Alto, CA, USA;
955. Clinic for Laryngology, Rhinology and Otology,
Hannover Medical School, Germany;
956. Centre for Aboriginal Studies, Curtin University,
Perth, WA, Australia;
957. Biomedical Engineering Department, Iran Univer-
sity of Science and Technology, Tehran, Iran;
958. Anesthesiology, University of California San Fran-
cisco, CA, USA;
959. Mechanical Engineering, Khalifa University of Sci-
ence and Technology, Abu Dhabi, UAE;
960. Horticultural Sciences, University of Florida,
Gainesville, FL, USA;
961. Centre for Biodiscovery and Molecular Devel-
opment of Therapeutics, Australian Institute of Tropical
Health andMedicine, James Cook University, Cairns, QLD,
Australia;
962. CINTESIS, Faculty of Medicine, University of
Porto, Portugal;
963. Medical Research Center, Shaoxing People’s Hos-
pital, Zhejiang, China;
964. Department Transfusion Medicine, National Insti-
tutes of Health, Bethesda, MD, USA;
965. Department of Biotechnology, All India Institute of
Medical Sciences (AIIMS), New Delhi, India;
966. Biochemistry, Microbiology and Immunology, Uni-
versity of Ottawa, ON, Canada;
967. Division of Mental Health and Addiction, Institute
of Clinical Medicine, University of Oslo, Norway;
968. Department of Radiology, University Medical Cen-
ter Groningen, University of Groningen, Netherlands;
969. School of Nursing, The University of Hong Kong,
Hong Kong, China;
970.Urology, TokyoMedical University IbarakiMedical
Center, Japan;
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972. Division of Immunotherapy, Institute of Human
Virology and Department of Surgery, University of
Maryland, Baltimore, MD, USA;
973. Division of Molecular Biology and Human Genet-
ics, Faculty of Medicine and Health Sciences, Stellenbosch
University, South Africa;
974. College of Biological Sciences, China Agricultural
University, Beijing, China;
975.Graduate School of Pharmaceutical Sciences,Osaka
University, Japan;
976. Biochemistry, University of Washington, Seattle,
WA, USA;
977. Institute of Bioscience and BioResources, National
Research Council of Italy, Naples, Italy;
978. Physics, Université de Lyon, France;
979.Center for Social Psychology, Faculty of Psychology,
University of Basel, Switzerland;
980. Centre for Molecular Oncology, Barts Cancer Insti-
tute, Queen Mary University of London, London, UK;
981. Samples, Phenotypes & Ontologies Team, Euro-
pean Bioinformatics Institute (EMBL-EBI), Cambridge,UK;
982. Faculty of Arts and Education, Charles Sturt Uni-
versity, Bathurst, NSW, Australia;
983. Helmholtz Institute of Biotechnology, State Key
Laboratory of Microbial Technology, School of Life Sci-
ences, Shandong University, Shandong, China;
984. Department of Biology, Shantou University,
Guangdong, China;
985. Institute of Biomedical Sciences, Shanxi University,
Shanxi, China;
986.Computational Biology, St. Jude Children’s Research
Hospital, Memphis, TN, USA;
987. College of Bioinformatics Science and Technology,
Harbin Medical University, Heilongjiang, China;
988. Radiology and Imaging Sciences, National Insti-
tutes of Health, Bethesda, MD, USA;
989. Department of Biological Sciences, Georgia Insti-
tute of Technology, Atlanta, GA, USA;
990. XtalPi Inc., Cambridge, MA, USA;
991. Bioinformatics, Instituto de Investigación en
Biomedicina de Buenos Aires (IBioBA) - CONICET -
Partner Institute of the Max Planck Society, Buenos Aires,
Argentina;
992. Save Sight Institute, University of Sydney, NSW,
Australia;
993. Australian Centre for Precision Health, University
of South Australia Cancer Research Institute, University of
South Australia, Adelaide, SA, Australia;
994. Key Laboratory of Functional Protein Research
of Guangdong Higher Education Institutes, Institute of
Life and Health Engineering, Jinan University, Guangdong,
China;
995. Epidemiology,Human Genetics and Environmental
Sciences, The University of Texas Health Science Center at
Houston, TX, USA;
996. Department of Microbiology and Immunology,
Weill Cornell Medicine, NY, USA;
997. Biotechnology Laborary, Guangdong Institute of
Applied Biological Resources, Guangdong, China;
998. College of Life Science, Shandong Normal Univer-
sity, Jinan, China;
999. Life Sciences Department, Shandong University,
Shandong, China;
1000. Integrative Microbiology Research Centre, South
China Agriculture University, Guangzhou, Guangdong,
China;
1001. Crop Molecular Improving Laboratory, Liaoning
Academy of Agricultural Sciences, Liaoning, China;
1002. Medical Biophysics, Lawson Health Research
Institute, London, ON, Canada;
1003. Infrastructure Engineering, University of Mel-
bourne, Parkville, VIC, Australia;
1004. Faculty of Health, University of Canberra, ACT,
Australia;
1005.MRC Cognition & Brain Sciences Unit, University
of Cambridge, UK;
1006. Biostatistics and Bioinformatics, Emory Univer-
sity, Atlanta, GA, USA;
1007. Anesthesiology and Critical Care Medicine, Johns
Hopkins School of Medicine, Baltimore, MD, USA;
1008. The School of Animal Rural and Environmental
Sciences, Nottingham Trent University, Nottingham, UK;
1009. Biosciences, University of Exeter, UK;
1010. Hillingdon Hospitals NHS Foundation Trust,
London, UK;
1011.MRC/CSO Social and Public Health Sciences Unit,
University of Glasgow, UK;
1012. ICU Evaggelismos Athens Hospital, National and
Kapodistrian University of Athens, Greece;
1013. Biological Sciences, The University of Newcastle,
Callaghan, NSW, Australia;
1014. Centre for Innovative Research Across the Life
Course, Faculty of Health and Life Sciences, Coventry
University, UK;
1015. Service of Endocrinology,Diabetes andMetabolism,
Lausanne University Hospital, Switzerland;
1016. School of Community Health, Charles Sturt Uni-
versity, Bathurst, NSW, Australia;
1017. Institute for Global Food Security, Queen’s Uni-
versity Belfast, UK;
1018 Institute of Policy Studies, National University of
Singapore;
1019. Intitute doe Medicine and Engineering, University
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1020. Cold Spring Harbor Laboratory, NY, USA;
1021. EECS, University of Michigan, MI, USA;
1022. Centre for Blood Research, The University of
British Columbia, Vancouver, BC, Canada;
1023. Faculty of Health Sciences, Department of Health
and Care Sciences, UiT - The Arctic University of Norway,
Tromsø, Norway;
1024. Physiotherapy,Hospital of Clinics of Porto Alegre,
Brazil;
1025. Medical school, University Paris Descartes, Paris,
France;
1026. Institute of Crop Sciences, National Key Facility
for Crop Gene Resources and Genetic Improvement, Chi-
nese Academy of Agricultural Sciences, Beijing, China;
1027. Experimental-Clinical and Health Psychology,
Ghent University, Belgium;
1028. Bioinformatics &
Structural Biology, Indian Institute of Advanced Research,
Gujart, India;
1029. Laboratory of Molecular Medicine, Bambino Ges.
Children’s Research Hospital, Rome, Italy;
1030. Center of Infectious Disease - Parasitology, Uni-
versity of Heidelberg, Germany;
1031. Electrical Engineering, Stanford University, Palo
Alto, CA, USA;
1032. Biology, University of Cádiz, Andalusia, Spain;
1033. general surgery, Mansoura University Hospital,
Egypt;
1034. Virology pole, Institut Pasteur de Dakar, Senegal;
1035.Division of Cancer &Genetics, Cardiff University,
UK;
1036. Food Safety and Environmental Microbiology,
Centre of Expertise and Biological Diagnostic of Cameroon,
Yaoundé, Cameroon;
1037. Laboratory of Thin Films and Photovoltaics, Swiss
Federal Laboratories for Materials Science and Technology,
Dübendorf, Switzerland;
1038. Assiut Urology and Nephrology Hospital, Faculty
of Medicine, Assiut University, Assiut, Egypt;
1039. GEE and IHA, University College London, UK;
1040. University of Derby Online Learning, University
of Derby, UK;
1041. Family, Population and Preventive Medicine,
Stony Brook University, NY, USA;
1042. Molecular Medicine Division, Walter and Eliza
Hall Institute, Melbourne, VIC, Australia;
1043. Northern Institute for Cancer Research, Newcas-
tle University, Newcastle upon Tyne, UK;
1044. Clinical Dementia Research, German Center for
Neurodegenerative Diseases, Bonn, Germany;
1045. UMR 7144, Station Biologique, Sorbonne Univer-
sité, CNRS, France;
1046. Odontoestomatologia, University of Barcelona,
Spain;
1047. Computer Science, Janelia Research Campus,
Ashburn, VA, USA;
1048. Centre for Tropical Medicine and Global Health,
University of Oxford, UK;
1049. ARTORG Center for Biomedical Engineering
Research, University of Bern, Switzerland;
1050. Eccles Institute of Neuroscience, John Curtain
School of Medical Research, The Australian National Uni-
versity, Canberra, ACT, Australia;
1051. Metabolic Biology, John Innes Centre, Norwich,
UK;
1052. Genomics and Bioinformatics Research Unit,
USDA Agricultural Research Service, Raleigh, NC, USA;
1053. Holzinger Group, Institute for Medical Informat-
ics, Statistics and Documentation,Medical University Graz,
Austria;
1054. Pharmacy, Ajou University, Suwon, Korea;
1055. School of Energy and Environment, City Univer-
sity of Hong Kong, Hong Kong, China;
1056. School of Kinseiology, The University of British
Columbia, Vancouver, BC, Canada;
1057. Department of Biology, Marine Biology Section /
University of Copenhagen, Denmark;
1058. Department of Communication, University of
Vienna, Austria;
1059. School of Social Sciences, University of Dundee,
UK;
1060. Institute of Botany, Technische Universitat
Dresden, Germany;
1061. Division of Structural Biology, University of
Oxford, UK;
1062. Medicine, National University Health System,
Singapore;
1063. School of Biological Sciences, University of
Canterbury, Christchurch, New Zealand;
1064. Focused Research Unit for Molecular Diagnostic
and Clinical Research, University Hospital of Southern
Denmark, Denmark;
1065. Primary Care Health Sciences, University of
Oxford, UK;
1066. National Institute of Neurological Disorders and
Stroke (NINDS), National Institutes of Health, Bethesda,
MD, USA;
1067. Verna and Marrs McLean Department of
Biochemistry and Molecular Biology, Baylor College of
Medicine, Houston, TX, USA;
1068. Department of Public Health Nursing, Faculty of
Nursing, Adnan Menderes University Aydin, Turkey;
1069.Department of Neurology IC,Oasi Research Insti-
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1070.Weldon School of Biomedical Engineering, Purdue
University, West Lafayette, IN, USA;
1071. King’s Centre forMilitary Health Research, King’s
College London, UK;
1072. Department of Infectious Diseases Epidemiology,
LSHTM, London, UK;
1073. BMWZ -Organic chemistry, University Hannover,
Germany;
1074. Department of Physiology and Pathophysiology,
School of BasicMedical Sciences, Xi’an Jiaotong University,
Shaanxi, China;
1075. School of Pharmacy andMedical Sciences, Univer-
sity of South Australia, Adelaide, SA, Australia;
1076. Department of Physical Education, Federal Uni-
versity of Santa Catarina, Florianópolis, Brazil;
1077. Department of Oncology, Nanfang Hospital,
Southern Medical University, Guangzhou, China;
1078. Hansen Experimental Physics Laboratory,
Stanford University, Palo Alto, CA, USA;
1079. Institute of Translational Medicine, Shenzhen Sec-
ond People’s Hospital, The First Affiliated Hospital of
Shenzhen University, Guangdong, China;
1080. Department of Statistics and Actuarial Science,
The University of Hong Kong, Hong Kong, China;
1081. Department of Mechanical Engineering, Univer-
sity College London, UK;
1082. Laboratory of Microbial Immunity, Singapore
Immunology Network, Agency for Science, Technology and
Research (A*STAR), Singapore;
1083. State Key Laboratory of Powder Metallurgy,
Central South University, Hunan, China;
1084. Institute of Applied Health Sciences, University of
Aberdeen, UK;
1085. Biomedical Engineering, University of Bridgeport,
CT, USA;
1086. Pharmaceutical Sciences, Texas Tech University
Health Sciences Center, Lubbock, TX, USA;
1087. Ecosystem and Conservation Sciences, University
of Montana, Missoula, MT, USA;
1089. Department of Systems Neuroscience, University
of Goettingen, Germany;
1090. School of Public Affairs, Penn State Harrisburg,
PA, USA;
1091. Bristol Medical School, University of Bristol, UK;
1092. Water Resources and Environmental Model-
ing, Czech University of Life Sciences, Prague, Czech
Republic;
1093.Neurology,Gardner Family Center for Parkinson’s
Disease andMovement Disorders, University of Cincinnati,
OH, USA;
1094. Melbourne School of Population and Global
Health, University of Melbourne, Parkville, VIC, Australia;
1095. Christie Patient Centred Research, The Christie
NHS Foundation Trust, Manchester, UK;
1096. Environmental Health Science and Engineering,
Jimma University;
1097. Laboratory of Systems Genetics, National Heart,
Lung, and Blood Institute, Bethesda, MD, USA;
1098. Department of Medicine, University of Oslo,
Norway;
1199. Medicine, University of Sydney, NSW, Australia;
1100. Clarendon Laboratory, Department of Physics,
University of Oxford, UK;
1101. Biochemistry, University of Cambridge, UK;
1102. Biochemical Plant Physiology, Heinrich Heine
University, Duesseldorf, Germany;
1103. Department of Respiratory Medicine, Norfolk
and Norwich University Hospital NHS Foundation Trust,
UK;
1104. Imaging, Cleveland Clinic Lou Ruvo Center for
Brain Health, Las Vegas, NV, USA;
1105. Nutrition and Dietetics, College of Nursing
and Health Sciences, Flinders University, Adelaide, SA,
Australia;
1106. School of Medicine, University of Dundee, UK;
1107. Laboratory of Optics and Dynamics of Biological
Systems, Novosibirsk State University, Russia;
1108. Department of Mathematics, University of
Padova, Italy;
1109. Clinical Research, London School of Tropical
Medicine, UK;
1110. Sciences naturelles, UQO, Ripon, QC, Canada;
1111. Faculty of Law, Lund University, Lund,
Sweden;
1112. Department of Microbiology and Immunology,
University of Gothenburg, Sweden;
1113. Biology Department, Stanford University, Palo
Alto, CA, USA;
1114. Department of Genetics and Biosystematics, Uni-
versity of Gdansk, Poland;
1115. Kachwekano Zardi, National Agricultural
Research Organization (NARO), Entebbe, Uganda;
1116. Bachelor Program in Interdisciplinary Studies,
National Yunlin University of Science &
Technology, Yunlin County, Taiwan;
1117. Clinical Genome Analysis Branch, National Can-
cer Center, Goyang, Korea;
1118. Danish Research Institute of Translational Neuro-
science (DANDRITE), Department of Biomedicine, Aarhus
University, Aarhus, Denmark;
1119. Biostatistics, Yale University, New Haven, CT,
USA;
1120.Centre de Recherches Insulaires et Observatoire de
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UPVD-CNRS USR 3278 CRIOBE, University of Perpignan
via Domitia, France;
1121. Mathematics and Computer Sciences, Eduardo
Mondlane University, Maputo, Mozambique;
1122. Department of Old Age Psychiatry and Psy-
chotherapy, University of Bern, Switzerland;
1123. Kinesiology and Health Science, Biola University,
La Mirada, CA, USA;
1124. Department of Surgery and Medical-Surgical Spe-
cialties, University of Catania, Italy;
1125. Laboratory of Cytology of Unicellular Organisms,
Institute of Cytology RAS, Saint Petersburg, Russia;
1126. Faculty of Engineering and Information Tech-
nology, University of Wollongong, Wollongong, NSW,
Australia;
1127. School of Chemistry and Chemical Engineering,
Beijing Institute of Technology, Beijing, China;
1128. Food Processing, Research Institute of Food Sci-
ence and Technology (RIFST), Mashhad, Iran;
1129. Cell and Developmental Biology, Centre for
Genomic Regulation, Barcelona, Spain;
1130. Queensland Alliance for Agriculture and Food
Innovation, The University of Queensland, Brisbane, QLD,
Australia;
1131. Cell Biology, Rostock University Medical Center,
Germany;
1132. Genetics and Genomics, The Roslin Institute, Uni-
versity of Edinburgh, UK;
1133. Biochemistry, College of Medicine, Mohammed
Bin Rashid University of Medicine and Health Sciences,
Dubai, UAE;
1134. Genomics Centre & Centre for Integrative Ecol-
ogy, Deakin University, Geelong, VIC, Australia;
1135. Division of Rehabilitation and Agein, University
of Nottingham, UK;
1136. Engineering, University of Nottingham, UK;
1137. Immunology, Garvan Institute, Sydney, NSW,
Australia;
1138. Auckland Bioengineering Institute, University of
Auckland, New Zealand;
1139.Department ofMedical Parasitology and Infection
Biology, Swiss Tropical and Public Health Institute, Univer-
sity of Basel, Switzerland;
1140. Inhalation Toxicology, Fraunhofer Institute for
Toxicology and Experimental Medicine (ITEM), Hannover,
Germany;
1141. Department of Rheumatology and Internal
Medicine, Wroclaw Medical University, Poland;
1142. BCRT, Charité Medical University of Berlin,
Germany;
1143. Public Health, The University of Hong Kong,
Hong Kong, China;
1144. Experimental Psychology, University of Oxford,
UK;
1145. School of Life Sciences, Hubei Key Laboratory of
Genetic Regulation and Integrative Biology, Central China
Normal University, Hubei, China;
1146. Department for Internal Medicine II, University
Clinic Krems, Karl Landsteiner University for Health
Sciences;
1147. Anesthesia and Pain Medicine, University Health
Network and University of Toronto, ON, Canada;
1148. Institute of Earth and Environmental Science,
University of Potsdam, Germany;
1149. Department for Health, University of Bath,
UK;
1150. Institute of Organic Chemistry, Justus-Liegbig
University, Giessen, Germany;
1151. Computational and RNA Biology, University of
Copenhagen, Denmark;
1152. Bedford Institute of Oceanography, Fisheries and
Oceans Canada, Dartmouth, NS, Canada;
1153. Integrative Medicine & Clinical Naturopathy,
Institute for Social Medicine, Epidemiology and Health
Economics, Charité
Medical University of Berlin, Germany;
1154. Physical Biology, BMLS,CEF-MC,Goethe Univer-
sität, Frankfurt am Main, Germany;
1155. Viral Diseases, Sciensano, Ixelles, Belgium;
1156. Department of Psychiatry, Faculty of Medicine,
Public Health and Nursing, Gadjah Mada University,
Yogyakarta, Indonesia;
1157. Anatomy and Structural Biology, Albert Einstein
College of Medicine, New York City, NY, USA;
1158. Nephrology and Hypertension, St. Marianna Uni-
versity, Kanagawa, Japan;
1159. Office of the Queensland Chief Scientist, Depart-
ment of Environment and Science, Queensland Govern-
ment, Brisbane, QLD, Australia;
1160. Department of Surgical Sciences, Section of
Vascular Surgery, Uppsala University, Uppsala, Sweden;
1161. Animal Science, University of Connecticut, Storrs,
CT, USA;
1162. Research, Children’s Cancer Hospital, Cairo,
Egypt;
1163. Department of Earth, Ocean, and Atmospheric
Science, Florida State University, Tallahasse, FL, USA;
1164. Unité Biologie Fonctionnelle et Adaptative (BFA)
CNRS UMR8251, Université Paris Diderot, Paris, France;
1165. School of Biochemistry, University of Bristol, UK;
1166. Department of Anatomy, Faculty of Medicine,
Trakia University, Stara Zagora, Bulgaria;
1167. Bio Pilot Plant, Leibniz Institute for Natural Prod-
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1168. Institute of Research and Development, Duy Tan
University, Da Nang, Vietnam;
1169. Helsinki Institute of Life Science (HiLIFE),
University of Helsinki, Finland;
1170. Department of Animal Biology, Federal University
of Technology Minna, Nigeria;
1171. Institute of Chinese Medical Sciences, University
of Macau, Guangdong, China;
1172. Australian Institute for Bioengineering and Nan-
otechnology, The University of Queensland, Brisbane,QLD,
Australia;
1173. Research Institute of Petroleum Industry (RIPI),
NIOC, Tehran, Iran;
1174. Bioanalysis, Ghent University, Belgium;
1175. Department of Dermatology, The First Affiliated
Hospital, Sun Yat-sen University, Guangzhou, Guangdong,
China;
1176. School of Business, Dalian University of Technol-
ogy, Liaoning, China;
1177. Faculty of Kinesiology, University of Calgary, AB,
Canada;
1178. Department of Psychological Medicine, Weston
Education Centre, King’s College London, UK;
1179. Chief Scientist, The George Institute for Global
Health, Sydney, NSW, Australia;
1180. Radiology and Chemistry, UCSF, San Francisco,
CA, USA;
1181. Griffith Institute for Drug Discovery, Griffith Uni-
versity, Brisbane, QLD, Australia;
1182. Centre of Biology and Health Sciences,Mackenzie
Presbyterian University, São Paulo, Brazil;
1183. Neuropsychiatry, University of Pennsylvania,
Philadelphia, PA, USA;
1184. School of Environmental andMunicipal Engineer-
ing, Tianjin Chengjian University, Tianjin, China;
1185. Shandong Provincial Key Laboratory of Bio-
physics, College of Physics and Electronic Information,
Dezhou University, Dezhou, China;
1186. Int Med-Hematology/Oncology, University of
Michigan, MI, USA;
1187. College of Life Sciences, Henan Agricultural Uni-
versity, Zhengzhou, China;
1188. Department of Transufusion Medicine, National
Institutes of Health, Bethesda, MD, USA;
1189. Beijing Children’s Hospital, Capital Medical Uni-
versity, Beijing, China;
1190. Public health, The University of Tokyo, Japan;
1191. Biomedical Genomics and Oncogenetics Research
Laboratory, Faculty of Sciences and Techniques of Tangier,
Abdelmalek Essaadi University, Morocco;
1192. The First Affiliated Hospital, Sun Yat-sen Univer-
sity, Guangzhou, Guangdong, China;
1192. Department of Medicine, University of Illinois at
Chicago, IL, USA;
1194. Department of Occupational Health, School of
Public Health, Shaanxi University of Chinese Medcine,
Shaanxi, China;
1195. Department of Critical Care Medicine, Affiliated
Hospital of Zunyi Medical University, Guizhou, China;
1196. State Key Laboratory of Pathogen and Biosecurity,
Beijing Institute ofMicrobiology and Epidemiology, Beijing,
China;
1197. Key Laboratory of Neonatal Disease, Ministry of
Health, Shanghai, China;
1198. Institute of Biophysics, Dezhou University,
Shandong, China;
1199. Pathology, Fudan University Shanghai Cancer
Center, Shanghai, China;
1200. Department of Physics, Covenant University, Ota,
Nigeria;
1201. Institute of Evolutionary Biology, University of
Edinburgh, UK;
1202. Department of Physical Therapy and Health
Rehabilitation, Prince Sattam Bin Abdulaziz University,
Al Kharj, Saudi Arabia;
1203. Chemical Engineering, Loughborough University,
UK;
1204. Physiotherapy, Umm Al-Qura University, Mecca,
Saudi Arabia;
1205. Department of Computer Science, University of
Liverpool, UK;
1206. Cognitive Science, Lund University, Malmö,
Sweden;
1207. Department of Public and Environmental Health,
National Open University of Nigeria, Abuja, Nigeria;
1208. Department of Social Policy and Intervention,
University of Oxford, UK;
1209. Physics of Complex Systems, Weizmann Institute
of Science, Rehovot, Israel;
1210. Department of Biology and Ecology, Faculty of
Science, University of Ostrava, Czech Republic;
1211. Agricultural Sciences, University of Helsinki,
Finland;
1212. Bioinformatics Unit, Max Planck Institute of
Immunobiology and Epigenetics, Freiburg, Germany;
1213. Mathematics Education, University of Regens-
burg, Germany;
1214. Public Health, Ghana Health Services;
1215. The Wales Centre for Podiatric Studies, Cardiff
Metropolitan University, Cardiff, UK;
1216. Institute of Public Health - Section of Hygiene,
Catholic University of the Sacred Heart, Rome, Italy;
1217. Computational Bioscience Program, University of
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1218. Department of Laboratorial Science and Technol-
ogy, School of Public Health, Peking University, Beijing,
China;
1219.Menzies Centre for Health Policy, School of Public
Health, University of Sydney, NSW, Australia;
1220. College of Life Sciences, Heilongjiang University,
Harbin, China;
1221. Department of Computer Science, University of
Southern California, Los Angeles, CA, USA;
1222. Department of Electrical and Computer Engineer-
ing, University of Auckland, New Zealand;
1223. College of Life Sciences, Zhejiang Sci-Tech Univer-
sity, Zhejiang, China;
1224. College of Chemistry and Chemical Engineering,
Xianyang Normal College, Shannxi, China;
1225. Research Center of TCM Information Engineer-
ing, Beijing University of Chinese Medicine, Beijing, China;
1226. Department of Surgery, Seoul National University
Bundang Hospital, Seoul National University College of
Medicine, Seongnam, Korea;
1227.Maternal andChildHealth Division, International
Centre for Diarrhoeal Diseases Research, Bangladesh;
1228. Department of Forensic Medicine, University of
Copenhagen, Denmark;
1229. Biological Sciences, University of Southampton,
UK;
1230. Cardiac surgery, Niguarda Hospital, Milan, Italy;
1231. Hearing and Speech Sciences, Vanderbilt Univer-
sity, Nashville, TN, USA;
1232. Faculty of Biology, Medicine and Health, Univer-
sity of Manchester, UK;
1233. Clinic for Horses, University of Veterinary
Medicine Hannover, Germany;
1234. NeuroPSI - UMR9197, CNRS, France;
1235. Agricultural Economics, Bangladesh Agricultural
University;
1236. Department of Surgical Oncology, The Second
Affiliated Hospital of Zhejiang University, Zhejiang Univer-
sity, Hangzhou, Zhejiang, China;
1237. Laboratory of Medical Genetics, Harbin Medical
University, Heilongjiang, China;
1238. State Key Laboratory of Genetic Engineering,
Collaborative Innovation Center for Genetics and Develop-
ment, School of Life Sciences, Fudan University, Shanghai,
China;
1239. Biology, Natural History Museum of Denmark;
1240. Department of Psychology, University of
Saskatchewan, Saskatoon, SK, Canada;
1241. Laboratoire Matière et Systèmes Complexes, Uni-
versité Paris Diderot, France;
1242. Epidemiology and Biostatistics, Bahir Dar Univer-
sity, Ethiopia;
1243. Centre of Studies in Geography and Spatial Plan-
ning (CEGOT), University of Coimbra, Portugal;
1244. Computer Science and Engineering, University of
Nebraska-Lincoln, NE, USA;
1245. Epidemiology, University Medical Center Gronin-
gen, University of Groningen, Netherlands;
1246. Department of Radiology, University College
London Hospital NHS Foundation Trust, and Division
of Surgery & Interventional Science, University College
London, London, UK;
1247. Department of Neurology and Neurosurgery,
South Central High Specialty Hospital, Pemex, Mexico;
1248. College of Information Science and Engineer-
ing, Shandong Agricultural University, Taian, Shandong,
China;
1249. College of Life Sciences, Sichuan University,
Sichuan, China;
1250. National drug Research Institute, Curtin Univer-
sity, Perth, WA, Australia;
1251. Gibson Lab, Stowers Institute for Medical
Research, Kansas City, MO, USA;
1252. Bacteriology and Epidemiology, Wageningen
Bioveterinary Research, Lelystad, Netherlands;
1253. General Practice, University Medical Center
Göttingen, Germany;
1254. Novo Nordisk Foundation Center for Protein
Research, Proteomics Program, Faculty of Health andMed-
ical Sciences, University of Copenhagen, Denmark;
1255. Department of Rheumatology and Immunol-
ogy, Guangdong Second Provincial General Hospital,
Guangzhou, China;
1256. Biomedical Rngineering, Erasmus University
Medical Center, Rotterdam, Netherlands;
1257. Pharmacology and Toxicology, University Medi-
cal Center Goettingen, Goettingen, Germany;
1258. Graduate School of Biomedical & Health Sci-
ences, Hiroshima University, Japan;
1259. Science and Engineering, University of the Sun-
shine Coast, QLD, Australia;
1260. Center for Advancing Electronics Dresden, Tech-
nische Universitat Dresden, Germany;
1261. School of Health Sciences, University of Iceland,
Reykjavík, Iceland;
1262. Health Promotion, Ministry of Health and Child
Care, Zimbabwe;
1263. Material Science and Engineering, The Ohio State
University, Columbus, OH, USA;
1264. Computational and Systems Biology, University of
Pittsburgh, PA, USA;
1265. School of Chemical Biology & Biotechnology,
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1266. School of Materials, University of Manchester,
UK;
1267. DPECS, Erasmus University Rotterdam, Nether-
lands;
1268. Molecular Biology, Centro de Biologia Molecular
Severo Ochoa, Madrid, Spain;
1269. Radiotherapy and Imaging, The Institute of Can-
cer Research, London, UK;
1270. Neurology, Ewha Womans University School of
Medicine and Ewha Medical Research Institute, Seoul,
Korea;
1271. Plastic and Reconstructive Surgery, Matsunami
General Hospital, Kasamatsu, Japan;
1271. Department of Dermatology, University Medical
Center Groningen, University of Groningen, Netherlands;
1272. Centre for Global Health Research, University of
Edinburgh, UK;
1274. Department of Construction Management,
Harbin Institute of Technology, Heilongjiang, China;
1275. Institute of Zoology, University of Veterinary
Medicine Hannover, Germany;
1276. National Laboratory of Solid State Microstruc-
tures, Department of Physics, and Collaborative Innovation
Center of Advanced Microstructures, Nanjing University,
Nanjing, China;
1277. Proteomics, Biomedical Research Foundation,
Academy of Athens, Greece;
1278. Genomics, ICAR-National Research Centre on
Plant Biotechnology, New Delhi, India;
1279. School of Public Health, The University of Hong
Kong, Hong Kong, China;
1280. Health Sciences, George Davies Centre for
Medicine, University of Leicester, UK;
1281. Bioengineering, University of Illinois at Chicago,
IL, USA;
1282. Hellenic Cord Blood Bank, Biomedical Research
Foundation Academy of Athens, Greece;
1283. Beijing Advanced Innovation Center for Structural
Biology, Tsinghua University, Beijing, China;
1284. Faculty of Health andWellbeing, Sheffield Hallam
University, Sheffield, UK;
1285. Bioinformatics Institute, University of Missouri,
Columbia, MO, USA;
1286.Quality Functional Unit,Hospital DoctorMoliner,
Valencia, Spain;
1287. Plants and Crops, Ghent University, Belgium;
1288. Department of Biomedical and Neuromotor Sci-
ences, University of Bologna, Italy;
1289. Center for Micro-Biorobotics, Istituto Italiano di
Tecnologia, Genoa, Italy;
1290. Department of Bioinformtaics and Biostatistics,
Shanghai Jiao Tong University, Shanghai, China;
1291. Health System Strengthening, Baylor College of
Medicine Children’s Foundation - Uganda;
1292. Medical Cell BioPhysics, University of Twente,
Enschede, Netherlands;
1293. Department of Pharmaceutical Sciences, Univer-
sity of Kashmir;
1294. Biologic and Materials Sciences, University of
Michigan, MI, USA;
1295. Faculty of Health, Queensland University of Tech-
nology, Brisbane, QLD, Australia;
1296. School of Medicine, Shanghai Jiao Tong Univer-
sity, Shanghai, China;
1297. Surgery, Aga Khan University, Karachi, Pakistan;
1298. School of Veterinary Science, Massey University,
Auckland, New Zealand;
1399. Department of Clinical Psychology and Psy-
chotherapy, Institute of Psychology, University of Freiburg,
Germany;
1300. Centre for Integrative Ecology, Deakin University,
Melbourne, VIC, Australia;
1301. State Key Laboratory Of Molecular Reaction
Dynamics, Dalian Institute of Chemical Physics, Chinese
Academy of Sciences, Liaoning, China;
1302. Social Psychology, Tilburg University, Nether-
lands;
1303. Emergency Medicine, University of Wisconsin-
Madison, WI, USA;
1304. Learning Informatics Management and Ethics
(LIME), Karolinska Institute, Solna, Sweden;
1305. Graduate Program in Quantitative and Compu-
tational Biosciences, Baylor College of Medicine, Houston,
TX, USA;
1306. Department of Psychiatry, University Hospital of
Reims, France;
1307. Department of Inorganic and Analytical Chem-
istry, Rzeszow University of Technology, Poland;
1308. Centre for Biotechnology, Siksha O Anusandhan
Universityr, Odisha, India;
1309. School of Medicine and Public Health, The Uni-
versity of Newcastle, Callaghan, NSW, Australia;
1310. Institute of Health Promotion and Clinical Move-
ment Science, German Sport University Cologne, Germany;
1311. Department for Gynecology and Obstetrics, Uni-
versity Hospital Essen, Germany;
1312. Médecine Sociale et Préventive, Universite de
Montreal, Montreal, QC, Canada;
1313. Intitute for Separation and Process Technology,
University of Technology Clausthal, Germany;
1314. Edmond & Lily Safra Center for Brain Sciences,
Hebrew University of Jerusalem, Israel;
1315. Department of Pathology, University of California
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1316.Department of Physiotherapy,KathmanduUniver-
sity School of Medical Sciences, Dhulikhel, Nepal;
1317. Accounting and Finance, University of Limerick,
Ireland;
1318. Division of Nursing, Midwifery and Social Work,
School of Health Sciences, Faculty of Biology,Medicine and
Health, University of Manchester, UK;
1319. School of Biomedical Sciences, The University of
Queensland, Brisbane, QLD, Australia;
1320.Division of Psychiatry,University College London,
UK;
1321. Image Guided Therapies, Fraunhofer MEVIS,
Bremen, Germany;
1322. Polymer Science and Engineering, University of
Science and Technology of China, Anhui, China;
1323. Haematology-Oncology, National University
Health System, Singapore;
1324. Laboratory of Marine Biotechnology, Insti-
tute of Bioscience, Universiti Putra Malaysia, Selangor,
Malaysia;
1325. Breast Oncology, Sun Yat-sen University Cancer
Center, Guangzhou, China;
1326.Unit of Bacteriology-Virology,Centre de Recherche
Medicale et Sanitaire, Niamey, Niger;
1327. Laboratory Animal Centre, Bengbu Medical Col-
lege, Anhui, China;
1328. Pharmacology and Toxicology,Medical College of
Wisconsin, Wauwatosa, WI, USA;
1329. School of Chemistry, Physics and Mechanical
Engineering, Science and Engineering Faculty, Queensland
University of Technology, Brisbane, QLD, Australia;
1330. Institution for Social Medicine and Family
Medicine, School of Public Health, Zhejiang University,
Hangzhou, Zhejiang, China;
1331. School of Computer Science and Technology,
Harbin Institute of Technology, Heilongjiang, China;
1332. Electrical and Computer Engineering, Mississippi
State University, Mississippi State, MS, USA;
1333. Department of Molecular Biotechnology and
Health Sciences, University of Turin, Italy;
1334. Electrical and Computer Engineering, University
of Toronto, ON, Canada;
1335. Physiotherapy Department, School of Rehabilita-
tion, Tehran University of Medical Sciences, Iran;
1336. Department of Occupational Health, School of
Health, Shiraz University of Medical Sciences, Iran;
1337. Department of Forest Sciences, University of
Helsinki, Finland;
1338. Department of Surgery, Weifang Medical Univer-
sity, Weifang, China;
1339. School of Computational Science and Engineering,
Georgia Institute of Technology, Atlanta, GA, USA;
1340. Key Laboratory of Chemical Genomics, Peking
University Shenzhen Graduate School, Shenzhen, China;
1341. Computer Science and Technology, Tsinghua Uni-
versity, Beijing, China;
1342.Center for Excellence in Biomacromolecules, Insti-
tute of Biophysics, Chinese Academy of Sciences, Beijing,
China;
1343. Human Pathology, University of Messina &
AO Papardo Hospital Messina, Italy;
1344. Institute of Child Health, College of Medicine,
University of Ibadan, Nigeria;
1345. Paediatric Surgery, University Hospital of Alexan-
droupolis, Dragana, Greece;
1346. Faculty of Ophthalmology, College of Medicine,
King Faisal University, Al-Hasa, Saudi Arabia;
1347. Department of Hematology. Sultan Qaboos Uni-
versity Hospital, Al Khod, Oman;
1348. Gulfstream Genomics, Gulfstream Diagnostics,
Dallas, TX, USA;
1349. Institute of Molecular Medicine, University of
Southern Denmark, Denmark;
1350. Institute for Social Marketing, University of Stir-
ling, UK;
1351. Laboratory Sciences & Services Division, Interna-
tional Centre for Diarrhoeal Diseases Research,Bangladesh;
1352. Social Determinants of Health Research Center,
Saveh University of Medical Sciences, Saveh, Iran;
1353. Gakujutsu Shien Co. Ltd., Tokyo, Japan;
1354. Institute of Geochemistry, Chinese Academy of
Sciences, Guiyang, China;
1355. Medical School, University of Plymouth, UK;
1356. CDER/OPQ/OBP/DBRRII, U.S. Food and Drug
Administration, Silver Spring, MD, USA;
1357. Department of Endocrinology, Affiliated Hospital
of Jining Medical University, Shandong, China;
1358. Pediatric Hematology/Oncology, Children’s Hos-
pital & Medical Center, Omaha, NE, USA;
1359. PWMHU, SJOG Burwood Hospital and UNSW
Sydney, NSW, Australia;
1360. immunology, CHU de Toulouse, France;
1361. Medicine, Harvard Medical School, Boston, MA,
USA;
1362.Cardiology, Barts HealthNHS Trust, London,UK;
1363. Centre for Ecology, Evolution and Environmental
Changes, Azorean Biodiversity Group and Universidade
dos Açores, Azores, Portugal;
1364. Social Psychology, University of Valencia,
Spain;
1365. Department of Advanced Biomedical Sciences,
University of Naples ”Federico II”, Italy;
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1367. RIKEN Center for Integrative Medical Sciences,
Yokohama, Japan;
1368. Medicine, Columbia University Medical Center,
New York, NY, USA;
1369. Holistic Education Center, Mackay Medical Col-
lege, New Taipei City, Taiwan;
1370. Physiology, Southeast University, Jiangsu, China;
1371. Division of Epidemiology, Indian Council of Med-
ical Research, National Institute of Cholera and Enteric
Diseases, India;
1372. Department of Global Health, School of Public
Health, Peking University, Beijing, China;
1373. Centre for Musculoskeletal Outcomes Research,
Department of Surgical Sciences, Dunedin School of
Medine, University of Otago, Dunedin, New Zealand;
1374.Department of Neurology, Chang GungMemorial
Hospital Linkou Medical Center and College of Medicine,
Chang-Gung University, Taoyuan, Taiwan;
1375. Cardiology, Saint Luke’s Mid America Heart Insti-
tute, Kansas City, MO, USA;
1376. Biomedical Sciences and Pharmacy Departments,
College of Medicine, University of Malawi, Blantyre,
Malawi;
1377. Genomics Research Center, Academia Sinica,
Taipei, Taiwan;
1378. Instituto de Ciencias Biologicas,Universidade Fed-
eral de Goias, Goiânia, Brazil;
1379. Retina department, Clínica Vista, Lima, Perú
1380.Department of Immunology andOncology,National
Center for Biotechnology (CNB-CSIC), Madrid, Spain;
1381. Pathology Department, CHU Bicêtre, France;
1382. Biocuration, Bioself Communication, Marseille,
France;
1383. School of Biomedical Engineering, School of
Ophthalmology & Optometry and Eye Hospital, Wenzhou
Medical University, Zhejiang, China;
1384. Pediatrics I, Renmin Hospital, Hubei University of
Medicine, Hubei, China;
1385. Anesthesiology, Perioperative Care and Pain
Medicine, New York University School of Medicine, New
York, NY, USA;
1386. Histology, Zagazig University, Egypt;
1387. Department of Neurology, Peking University
Third Hospital, Beijing, China;
1388. Department of Pathology, College of Health Sci-
ences, Faculty of Basic Clinical Sciences, Ahmadu Bello
University, Zaria, Nigeria;
1389. School of Computer and Communication Engi-
neering, University of Science and Technology, Beijing,
China;
1390. Caribbean Institute for Health Research, The Uni-
versity of the West Indies, Jamaica;
1391. Human Pathology of the Adult and Evolutive Age
”Gaetano Barresi”, Section of General Surgery, University
of Messina, Italy;
1392. Ageing Clinical and Experimental Research
(ACER) Team, University of Aberdeen, UK;
1393. Ophthalmology, Massachusetts Eye Research and
Surgery Institution, Waltham, MA, USA;
1394. Child & Adolescent Psychiatry, Child Study Cen-
ter at Hassenfeld Children’s Hospital of New York at NYU
Langone, NY, USA;
1395. Department of Thoracic Surgery, National Cancer
Center / Cancer Hospital, Chinese Academy of Medical
Sciences, Beijing, China;
1396. Endowed Health Services Research, School of
Medicine, University of Puerto Rico, Mayagüez, PR,
USA;
1397. Pathology and Hamon Center for Therapeutic
Oncology Research, UT SouthwesternMedical Center, Dal-
las, TX, USA;
1398.Department of Anesthesia, PainManagement, and
Perioperative Medicine, Dalhousie University, Halifax, NS,
Canada;
1499. Faculty of Mathematics & Technology, Koblenz
University of Applied Sciences, Germany;
1400. VisMederi srl, Siena, Italy;
1401. Medicine, Ross University School of Medicine,
Miramar, FL, USA;
1402. Cancer Research UK and UCL Cancer Trials
Centre, University College London, UK;
1403. Department of Critical Care, University of
Alberta, Edmonton, AB, Canada;
1404. Critical Care Medicine, Dalhousie University,
Halifax, NS, Canada;
1405. Clinical Haematology, Palmerston North Hospi-
tal, New Zealand;
1406. Family Medicine, University of Ottawa, ON,
Canada;
1407. College of Engineering, China Agricultural Uni-
versity, Beijing, China;
1408. NHMRC Clinical Trials Centre, University of
Sydney, NSW, Australia;
1409. Division of Drug Discovery and Safety, Leiden
Academic Centre for Drug Research, Leiden University,
Netherlands;
1410. Biomedical Sciences Department of ESTESC -
Coimbra Health School, Polytechnic Institute of Coimbra,
Portugal;
1411.Department of Interventional Radiology, The First
Affiliated Hospital, Sun Yat-sen University, Guangzhou,
Guangdong, China;
1412. Pathology, Microbiology, and Immunology,
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1413. Infectious Diseases, American University of Beirut
Medical Center, Beirut, Lebanon;
1414. Pediatrics, University of New Mexico,
Albuquerque, NM, USA;
1415.Department of SocialWork, Social Care and Com-
munity Studies, Sheffield Hallam University, Sheffield, UK;
1416. Pulmonary Diseases, Critical Care & Environ-
mental Medicine, Tulane University School of Medicine,
New Orleans, LA, USA;
1417. Viral Hepatitis, Mechnikov Research Institute for
Vaccines and Sera, Moscow, Russia;
1418. Neurosurgery, Duke University Medical Center,
Durham, NC, USA;
1419. InternalMedicine,University Tübingen,Germany;
1420. Pediatrics, University of Ottawa, ON, Canada;
1421. Medicine, Penn State College of Medicine,
Hershey, PA, USA;
1422. Urology, University of Texas Health Science Cen-
ter at San Antonio, TX, USA;
1423. Department for Wound Infection Treatment and
Prevention, Vreden Russian Research Institute of Trauma-
tology and Orthopaedics, St. Petersburg, Russia;
1424. Medicine, Western University, London, ON,
Canada;
1425. Laboratoire Cancérologie Mammaire / Institut
J. Bordet, Université Libre de Bruxelles (ULB), Brussels,
Belgium;
1426.College of Life Science and Technology,Huazhong
University of Science and Technology, Hubei, China;
1427. Department for TB Control and Prevention,
Hangzhou Center for Disease Control and Prevention,
Zhejiang, China;
1428. Institute of Aging Research, School of Medicine,
Hangzhou Normal University, Zhejiang, China;
1429. Department of Rheumatology and Clinical
Immunology, Key Laboratory of Rheumatology and
Clinical Immunology, Ministry of Education, Peking Union
Medical College Hospital, Chinese Academy of Medical
Sciences and Peking UnionMedical College, Beijing, China;
1430.Department of Biotechnology, KaohsiungMedical
University, Taiwan;
1431. Oncology, West China Hospital, Sichuan, China;
1432. School of Medicine, University of California
Irvine, CA, USA;
1433. Diagnostics, Zoetis, Kalamazoo, MI, USA;
1434. Clinical Pathology Laboratory, Vito Fazzi General
Hospital, Lecce, Italy;
1435. Head and Neck Oncology Research, Aintree Uni-
versity Hospital NHS Trust, Liverpool, UK;
1436. Department of Otolaryngology, Head Neck
Surgery, Beijing Friendship Hospital, Capital Medical
University, Beijing, China;
1437. Trauma & Orthopaedics, Wrightington Hospital,
Wigan, Greater Manchester, UK;
1438. Physical and Environmental Sciences, University
of Toronto, Scarborough, ON, Canada;
1449. Microbiology and Immunology, University of
Rochester, NY, USA;
1440.Department of Psychiatry, Loyola UniversityMed-
ical Center, Maywood, IL, USA;
1441.Microbiology, Atkins Veterinary Services, Calgary,
AB, Canada;
1442.Microbiology, Golestan University of Medical Sci-
ences, Iran;
1443. CIAFEL, FADEUP, University of Porto, Portugal;
1444. Hematology-Oncology, Mashhad University of
Medical Science, Iran;
1445. Global Health, Stellenbosch University, South
Africa;
1446. Anaesthesiology, Kovai Medical Center and Hos-
pital, Tamilnadu, India;
1447. Saw Swee Hock School of Public Health,National
University of Singapore;
1448. Pediatric cardiology, Queen Alia Heart Institute,
Royal Medical Services, Amman;
1449. Department of Food Science and Biotechnology,
College of Biotechnology and Bioscience, Kangwon
National University, Chuncheon, Korea;
1450. Internal Medicine, Kakatiya Medical College,
Telangana, India;
1451. Otolaryngology, St. Paul’s Hospital, Vancouver,
Canada;
1452. Neurology, Kakatiya Medical College and
Mahatma Gandhi Memorial Hospital, Warangal, India;
1453. CIBAV Research Group, Veterinary Medicine
School, University of Antioquia, Medellin, Colombia;
1454. Paediatrics, King’s College Hospital NHS Trust,
London, UK;
1455. Neurosurgery, Carlo Besta Neurological Institute
Milan, Italy;
1456. Department of Clinical Microbiology and Micro-
bial Pathogenesis, School of Medicine, University of Crete,
Greece;
1457. Soft and Active Matter Group, Department of
Physics, Indian Institute of Science Education and Research
(IISER) Tirupati, Andhra Pradesh 517507, India;
1458. Center of Studies in Physical Activity Measure-
ments, School of Medicine and Health Sciences, Universi-
dad del Rosario, Bogota D.C, Colombia;
1459. Medicine, Rheumatology, St. Clares Mercy Hos-
pital, St. Johns, NL, Canada;
1460. Department of Community Dentistry and Pop-
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1461. Cardiology and Vascular Medicine, University
Hospital Essen, Germany;
1462. Endocrinology, University Hospital Basel,
Switzerland;
1463. Institute of Medical Genetics and Applied
Genomics, University Tübingen, Germany;
1464. Department of Medicine D, Division of General
Internal Medicine, Nephrology, and Rheumatolog, Univer-
sity Hospital Münster, Germany;
1465. Nutrition, Harvard TH Chan School of Public
Health, Boston, MA, USA;
1466. Department of Nephrology, University of
Kentucky, Lexington, KY, USA;
1467. Emergency Medicine, University of Missouri,
Columbia, MO, USA;
1468. Department of Anaesthesiology and Critical Care,
Medical Centre, University of Freiburg, Germany;
1469. Quality and Safety, Children’s Hospital of The
King’s Daughters, Norfolk, VA, USA;
1470. Research, IIHMR University, Rajasthan, India;
1471. Department of Internal Medicine, University of
Arkansas for Medical Sciences, Little Rock, AR, USA;
1472. Infectious Diseases, Cincinnati Children’s Hospi-
tal Medical Center, OH, USA;
1473. Mood Disorders Psychopharmacology Unit, Uni-
versity Health Network, Toronto, ON, Canada;
1474. Department of Medicine, University of California
Irvine, Orange, CA, USA;
1475. Center for Reliability Science and Technology,
Chang Gung University, Taoyuan, Taiwan;
1476. Gastroenterology, Profensa, La Pampa, Argentina;
1477. Centre for Global Development and Institute of
Applied Health Sciences, University of Aberdeen, UK;
1478.Ophthalmology,HarvardMedical School, Boston,
MA, USA;
1479. Department of Urology, University Hospitals
Leuven, Belgium;
1480. Medical School, University of Talca, Chile;
1481. Institute of Biotechnology and Department of
Life Science, National Tsing Hua University, Hsinchu,
Taiwan;
1482. College of Life Sciences, Chinese Academy of
Sciences, Beijing, China;
1483. Department of Obstetrics and Gynaecology,Med-
ical and Health Sciences, University of Auckland, New
Zealand;
1484. School of Clinical Medicine, University of Cam-
bridge, UK;
1485. Orthopaedics & Rehabilitation, University of
Florida, Gainesville, FL, USA;
1486. Otolaryngology, Massachusetts Eye and Ear Infir-
mary, Boston, MA, USA;
1487. Chongqing Key Laboratory of Molecular Oncol-
ogy and Epigenetics, The First Affiliated Hospital of
Chongqing Medical University, Chongqing, China;
1488. Department of Pulmonary &
Critical Care Medicine, Chinese PLA General Hospital,
Beijing, China;
1489. Department of Chemical Engineering, Tsinghua
University, Beijing, China;
1490. Institute of Intelligent Machines, Hefei Institutes
of Physical Science, Chinese Academy of Sciences, Anhui,
China;
1491. Department of Instrumental and Electrical Engi-
neering, Xiamen University, Fujian, China;
1492. Department of Pharmacology, Yonsei University
College of Medicine, Seoul, Korea;
1493. Nephrology, Walter Reed National Military Med-
ical Center, Bethesda, MD, USA;
1494. Department of Pediatrics, Eastern Virginia Med-
ical School, Children’s Hospital of The King’s Daughters,
Norfolk, VA, USA;
1495. Department of Mathematics, College of Science,
China Three Gorges University, Yichang, China;
1496. College of Information Engineering, Xiangtan
University, Hunan, China;
1497. Mood Disorders and Psychopharmacology, Uni-
versity Health Network, Toronto, ON, Canada
Funding
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